Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

Articles published in
J Virol
    August 2026
  1. ALYMOVA IV, Mekonnen B, Wang D, Kamal RP, et al
    N-linked glycosylation sites with low occupancy support sustained circulation of the A(H3N2) influenza A virus in the human population.
    J Virol. 2026 Aug 28:e0066226. doi: 10.1128/jvi.00662.
    >> Share

  2. BARRE RS, Nath H, Nogales A, Abdelwhab EM, et al
    NS-segment-based reporter influenza A viruses: engineering strategy, applications, and limitations.
    J Virol. 2026 Aug 26:e0109926. doi: 10.1128/jvi.01099.
    >> Share

  3. PULIT-PENALOZA J, Belser JA, Brock N, Kieran TJ, et al
    Risk assessment of avian influenza A(H5N5) virus from the first human case using the ferret model.
    J Virol. 2026 Aug 11:e0085626. doi: 10.1128/jvi.00856.
    >> Share

    July 2026
  4. MCCAFFREY KD, Esfahani BG, Elbehairy MA, McCormick AL, et al
    Molecular basis for protection and cross-protection by human antibodies targeting the parainfluenza virus hemagglutinin-neuraminidase protein.
    J Virol. 2026 Jul 31:e0050226. doi: 10.1128/jvi.00502.
    >> Share

  5. XU J, Chan H-w, Yang R, Wu X-R, et al
    Nicotine and cotinine enhance SARS-CoV-2 entry through distinct but complementary mechanisms in human respiratory epithelial cells.
    J Virol. 2026 Jul 31:e0097126. doi: 10.1128/jvi.00971.
    >> Share

  6. HE L, Su Y-WN, Zhang F, Moustafa IM, et al
    Recovery of proofreading-impaired SARS-CoV-2 reveals a mutator phenotype and an ExoN activity threshold for viability.
    J Virol. 2026 Jul 29:e0080926. doi: 10.1128/jvi.00809.
    >> Share

  7. CHEN X, Yan J, Li M, Liu H, et al
    c-Fos enhances influenza virus replication by stabilizing the M2 protein and promoting autophagosome accumulation.
    J Virol. 2026 Jul 27:e0091626. doi: 10.1128/jvi.00916.
    >> Share

  8. FAN M, Liu Z, Deng L, Zheng Y, et al
    LncRNA ckATP1A1-AS1 inhibits influenza A virus replication by mediating innate immune responses and suppressing viral nuclear import.
    J Virol. 2026 Jul 24:e0025926. doi: 10.1128/jvi.00259.
    >> Share

  9. BEETON K, Case JB
    Respiratory mucosal vaccines for emerging viruses: promise and challenges.
    J Virol. 2026 Jul 23:e0174825. doi: 10.1128/jvi.01748.
    >> Share

  10. ADENUGBA AR, Bohn P, Yu J, Fehrholz M, et al
    Sequence heterogeneity in pneumonia virus of mice reveals G gene-dependent modulation of virulence.
    J Virol. 2026;100:e0010326.
    >> Share

  11. MURRAY A, Nagaraj D, Schultz EM, Aloisio G, et al
    RSV can infect the human nasal epithelium via the basolateral route and shows distinct subgroup infectivity and basal cell tropism.
    J Virol. 2026;100:e0037426.
    >> Share

  12. GIL-REDONDO JC, Riomoros-Barahona V, Valiente L, Valbuena A, et al
    Different mechanisms for human rhinovirus survival in the presence of deleterious amino acid substitutions at virion protein-protein or RNA-protein interfaces.
    J Virol. 2026;100:e0051126.
    >> Share

  13. WILT I, Jolley AA, Rahman K, Lai KK, et al
    IFITM1 and IFITM3 cooperate to restrict virus entry in endolysosomes.
    J Virol. 2026;100:e0067726.
    >> Share

  14. CIMINSKI K, Reuther P, Rijkers R, de Vries RP, et al
    The receptor landscape of influenza A viruses.
    J Virol. 2026 Jul 16:e0144325. doi: 10.1128/jvi.01443.
    >> Share

  15. SHIRAZI R, Kim SY, Cruz A, Stumpff JP, et al
    RELMalpha establishes a permissive environment for influenza virus infection through direct effects on lung epithelial cells.
    J Virol. 2026 Jul 16:e0222525. doi: 10.1128/jvi.02225.
    >> Share

  16. JIA H, Lin C, Guo Y, Cai W, et al
    A neuraminidase-targeted nanobody confers broad protection against influenza B virus.
    J Virol. 2026 Jul 10:e0076226. doi: 10.1128/jvi.00762.
    >> Share

  17. ZHOU R, Yue M, Shen Q, Liu N, et al
    Glucagon-like peptide-1 receptor agonist prevents pulmonary fibrosis following acute COVID-19 infection associated with type 2 diabetes.
    J Virol. 2026 Jul 9:e0040126. doi: 10.1128/jvi.00401.
    >> Share

  18. BARRON-CASTILLO U, Berube N, Swan CL, Javed MA, et al
    Receptor profiling and growth assessment of influenza A virus in porcine mammary and non-mammary tissues and derived cells.
    J Virol. 2026 Jul 6:e0061526. doi: 10.1128/jvi.00615.
    >> Share

  19. LAMICHHANE P, Yang L, Santos C, Park H-S, et al
    Live human metapneumovirus vaccine candidates attenuated by temperature sensitivity mutations from human respiratory syncytial virus.
    J Virol. 2026 Jul 6:e0069226. doi: 10.1128/jvi.00692.
    >> Share

    June 2026
  20. KATO K, Okamura K, Nakamura Y, Iwata M, et al
    Influenza A virus infection induces initial proliferation of commensal Streptococcus pneumoniae in the larynx leading to dissemination into the lower respiratory tract.
    J Virol. 2026 Jun 29:e0055526. doi: 10.1128/jvi.00555.
    >> Share

  21. ZHANG Q, Zhang Y, Sun H, Li H, et al
    Single-cell and spatial transcriptomic profiling reveals distinct immune landscapes in murine lungs infected with H1N1 versus H5N1 influenza viruses.
    J Virol. 2026 Jun 29:e0074626. doi: 10.1128/jvi.00746.
    >> Share

  22. SUSMA B, Spronken M, van Nieuwkoop S, Kalverda B, et al
    Increased or decreased numbers of CpG dinucleotide motifs in the genome of influenza A virus do not affect in vitro virus phenotype.
    J Virol. 2026 Jun 22:e0004726. doi: 10.1128/jvi.00047.
    >> Share

  23. AO Z, Vendramelli R, Buyu M, Truong T, et al
    A VSV-vector vaccine simultaneously targeting H5N1 hemagglutinin and matrix protein 2 induces robust neutralizing and ADCC antibody responses and provides full protection against lethal H5N1 infection in a mouse model.
    J Virol. 2026 Jun 16:e0009726. doi: 10.1128/jvi.00097.
    >> Share

  24. HUI X, Tian X, Xue C, Ding S, et al
    KCMF1-mediated influenza A virus PB1 ubiquitination at K653 regulates viral replication.
    J Virol. 2026 Jun 15:e0048126. doi: 10.1128/jvi.00481.
    >> Share

  25. NGUYEN X-D, Le BT, Bleich J, Espada C, et al
    Environmental temperature and relative humidity shape post-emission aerosol fate and airborne influenza transmission.
    J Virol. 2026 Jun 15:e0063426. doi: 10.1128/jvi.00634.
    >> Share

  26. LV C, Wang S, Song M, Wu J, et al
    The nicotinamide phosphoribosyltransferase inhibitor FK866 restricts influenza A virus replication by perturbing viral polymerase activity.
    J Virol. 2026 Jun 15:e0059126. doi: 10.1128/jvi.00591.
    >> Share

  27. LIU Z, Fan M, Zeng Y, Zheng Y, et al
    Gga-miR-92-targeted TNFRSF1B inhibits the replication of influenza A virus by degrading TRAF3.
    J Virol. 2026 Jun 12:e0067426. doi: 10.1128/jvi.00674.
    >> Share

  28. ZHANG Q, Xin J, Wang C, Zhang X, et al
    Cleavage of TOM1 by the SARS-CoV-2 main protease NSP5 prevents autophagic degradation of viral envelope.
    J Virol. 2026 Jun 12:e0043426. doi: 10.1128/jvi.00434.
    >> Share

  29. XU S, Zhang Q, Xie X, Zhou M, et al
    A neutralizing nanobody targeting a conserved lateral patch on HA1 confers protection against multiple H7 avian influenza viruses.
    J Virol. 2026 Jun 11:e0056326. doi: 10.1128/jvi.00563.
    >> Share

  30. PENG M, Liu L, Li X, Yu X, et al
    Pre-pandemic contraction, phase-specific rate variation, and site-specific antigenic adaptation shape influenza A(H3N2) evolutionary dynamics in Hubei, China.
    J Virol. 2026 Jun 10:e0055626. doi: 10.1128/jvi.00556.
    >> Share

  31. VARGAS DA, Albornoz LL, Pena-Morales M, Ortiz Rojas HJ, et al
    Within-host SARS-CoV-2 diversity in immunocompromised patients during acute infection.
    J Virol. 2026 Jun 9:e0222425. doi: 10.1128/jvi.02224.
    >> Share

  32. YU H-M, Zhu M-L, Zhao Y-L, Tan J-X, et al
    Research progress on the association between viruses and cardiac diseases.
    J Virol. 2026 Jun 9:e0038326. doi: 10.1128/jvi.00383.
    >> Share


  33. CEIRR Risk Assessment Pipeline executive reports on H5N1 highly pathogenic avian influenza 2.3.4.4b, swine H1 1B.2, and H9N2 low pathogenicity avian influenza B4.7.2.
    J Virol. 2026 Jun 3:e0054526. doi: 10.1128/jvi.00545.
    >> Share

  34. STEARNS K, Marcink T, Pawlack E, Sobolik EB, et al
    Human parainfluenza virus 3 fusion protein cleavage: a key determinant of infection and spread.
    J Virol. 2026 Jun 3:e0212625. doi: 10.1128/jvi.02126.
    >> Share

  35. TURNER AH, Jaffrani SA, Kubinski HC, Ajayi DP, et al
    Rab11B is required for binding and entry of recent H3N2, but not H1N1, influenza A isolates.
    J Virol. 2026 Jun 2:e0211125. doi: 10.1128/jvi.02111.
    >> Share

  36. FAN L, Gao X, Feng W, Huang Q, et al
    SARS-CoV-2 ORF3a suppresses host antiviral interferon responses by promoting STUB1-mediated PTEN proteasomal degradation.
    J Virol. 2026 Jun 2:e0018626. doi: 10.1128/jvi.00186.
    >> Share

    May 2026
  37. LOES AN, Tarabi RAL, Li SH, Atkinson RK, et al
    Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccines.
    J Virol. 2026 May 27:e0031726. doi: 10.1128/jvi.00317.
    >> Share

  38. SIVARAJAN R, Kirchgatterer PC, Lawrenz J, Tanner-Matiz E, et al
    Tonic and early interferons defend against respiratory viruses in primary human lung organoid-derived air-liquid interface cultures.
    J Virol. 2026 May 20:e0210425. doi: 10.1128/jvi.02104.
    >> Share

  39. XU C, Peng Y, Liu S, Xie R, et al
    Cellular hnRNP D promotes influenza A virus replication by inhibiting TBK1-IRF3-mediated innate immune response.
    J Virol. 2026 May 13:e0025726. doi: 10.1128/jvi.00257.
    >> Share

  40. CHEN X, Zheng X, Zhang L, Cai X, et al
    Long noncoding RNA#61 synergizes with viral PA-X to augment pyroptosis and attenuate the virulence of highly pathogenic H5N1 influenza virus in mice.
    J Virol. 2026 May 12:e0221425. doi: 10.1128/jvi.02214.
    >> Share

  41. VAN PUL L, Rosendahl Huber SK, Jacobi R, Hendriks M, et al
    Cross-reactive antibody and T-cell responses after influenza virus infection in community-dwelling older adults.
    J Virol. 2026 May 12:e0040726. doi: 10.1128/jvi.00407.
    >> Share

  42. MCCABE M, Groves HE, Getty E, Campbell E, et al
    Age-dependent expression and antiviral activity of interferon epsilon in respiratory epithelium.
    J Virol. 2026 May 12:e0057825. doi: 10.1128/jvi.00578.
    >> Share

  43. LI P, Zheng Y-M, Liu S-L
    Altered infectivity, cell-cell fusion, and immune evasion of SARS-CoV-2 BA.3.2 and LP.8.1 variants.
    J Virol. 2026 May 12:e0001626. doi: 10.1128/jvi.00016.
    >> Share

  44. ZHANG L, Hoffmann M, Pohlmann S
    Lock out: targeting TMPRSS2 to block influenza and coronaviruses.
    J Virol. 2026 May 4:e0080725. doi: 10.1128/jvi.00807.
    >> Share

    April 2026
  45. DAINES R, Sadeyen J-R, Chang P, Iqbal M, et al
    Mapping hemagglutinin residues driving antigenic diversity in H5Nx avian influenza viruses.
    J Virol. 2026 Apr 30:e0009526. doi: 10.1128/jvi.00095.
    >> Share

  46. KOTANI N, Iwasa K, Amimoto T, Yamashita C, et al
    Pseudovirus-mediated proximity labeling identifies candidate host cell membrane proteins involved in viral attachment.
    J Virol. 2026 Apr 29:e0050726. doi: 10.1128/jvi.00507.
    >> Share

  47. CHEN L, Su H, Shang W, Nie T, et al
    SARS-CoV-2 3CLpro mutations T21I and E166A confer differential resistance to simnotrelvir, bofutrelvir, and ensitrelvir.
    J Virol. 2026 Apr 27:e0222325. doi: 10.1128/jvi.02223.
    >> Share

  48. NASIR A, Lee D, Avena LE, Berrueta DM, et al
    Predictive modeling of immune escape and antigenic grouping of SARS-CoV-2 variants.
    J Virol. 2026 Apr 27:e0022526. doi: 10.1128/jvi.00225.
    >> Share

  49. GUO D, Yu S, Ma K, Tao H, et al
    Concanavalin A targets phylogenetically conserved N-linked glycans on coronavirus spike proteins for broad-spectrum antiviral activity.
    J Virol. 2026 Apr 27:e0167925. doi: 10.1128/jvi.01679.
    >> Share

  50. ZHANG R, Jian X, Zhang Y, Sun Y, et al
    The oral nucleoside analogue inhibitor VV251 effectively inhibits coinfection by respiratory syncytial virus and influenza A virus.
    J Virol. 2026 Apr 21:e0000626. doi: 10.1128/jvi.00006.
    >> Share

  51. YILDIZ S, El Zahed SS, Villalon-Letelier F, Wang Q, et al
    Re-engineering segment 8 facilitates generation of a versatile live-attenuated influenza A virus vector platform for secretory protein delivery.
    J Virol. 2026 Apr 21:e0034726. doi: 10.1128/jvi.00347.
    >> Share

  52. BRENNAN JW, Wang G, Connor S, Wang X, et al
    A respiratory syncytial virus trailer sequence modulates viral replication and the generation and propagation kinetics of copy-back defective viral genomes.
    J Virol. 2026;100:e0018426.
    >> Share

  53. SALISCH F, Muller-Ruttloff C
    Behind the membranous curtain-lipid dynamics and functions in coronaviral replication.
    J Virol. 2026 Apr 21:e0175325. doi: 10.1128/jvi.01753.
    >> Share

  54. RAHEJA H, Sahu R, Ghosh T, Paul S, et al
    HuR enhances SARS-CoV-2 non-structural protein translation through the genomic 5'-UTR, by promoting polypyrimidine tract-binding protein binding.
    J Virol. 2026 Apr 16:e0027626. doi: 10.1128/jvi.00276.
    >> Share

  55. POZHIDAEVA A, Hoch JC, Pustovalova Y
    The DMV pore-forming TM2-Y region of SARS-CoV-2 nsp3 exhibits structural conservation beyond the coronavirus family.
    J Virol. 2026 Apr 3:e0203825. doi: 10.1128/jvi.02038.
    >> Share

    March 2026
  56. KONG W, Zhang J, Song Y, Song J, et al
    Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    J Virol. 2026 Mar 30:e0027026. doi: 10.1128/jvi.00270.
    >> Share

  57. XIU R, Wang Y, Cai W, Wang Q, et al
    Potent in vitro synergistic antiviral effects of the pan-coronavirus fusion inhibitor EK1 in combination with RBD-specific antibodies or M(pro) inhibitors.
    J Virol. 2026 Mar 30:e0007626. doi: 10.1128/jvi.00076.
    >> Share

  58. KIM K-H, Hwang HS, Pal SS, Tien Le CT, et al
    Type I interferon signaling is required for resistance to primary influenza virus infection and vaccine-induced long-term immunity.
    J Virol. 2026 Mar 27:e0022926. doi: 10.1128/jvi.00229.
    >> Share

  59. CIACCI ZANELLA G, Cardenas MI, Hutter CR, Snyder CA, et al
    Impact of maternal antibodies and weaning stress on the replication and transmission of human H3N2 influenza A in piglets.
    J Virol. 2026 Mar 27:e0197525. doi: 10.1128/jvi.01975.
    >> Share

  60. BUTH SA, Marin M, Zhang Y, Avinoam O, et al
    Cyclosporine A rescues the influenza virus fusion with IFITM3-expressing cells by relocating the restriction factor to intraluminal vesicles of multivesicular bodies.
    J Virol. 2026 Mar 25:e0204525. doi: 10.1128/jvi.02045.
    >> Share

  61. KURYSHKO M, Luttermann C, Bayoumi M, Mostafa A, et al
    Host-specific functional evolution of seal influenza A virus NS1 protein following avian-to-seal transmission.
    J Virol. 2026 Mar 24:e0165025. doi: 10.1128/jvi.01650.
    >> Share

  62. LIN S, Chen X, Luo M, Cui X, et al
    DIDS modulates VDAC1 oligomerization to suppress intrinsic apoptosis and attenuates in vitro and in vivo RSV infection.
    J Virol. 2026;100:e0220025.
    >> Share

  63. BAYUROVA E, Kostyushev D, Tikhonov A, Chulanov V, et al
    Broad-acting antivirals: the pursuit of pan-viral therapeutics in the era of pandemics.
    J Virol. 2026 Mar 23:e0007726. doi: 10.1128/jvi.00077.
    >> Share

  64. ADAM A, Wu W, Jones MC, Hao H, et al
    Respiratory syncytial virus infection induces heterologous protection against SARS-CoV-2 through gammadelta T cell-mediated trained immunity and the activation of SARS-CoV-2-reactive mucosal T cells.
    J Virol. 2026 Mar 18:e0165825. doi: 10.1128/jvi.01658.
    >> Share

  65. LIU B, Yu H, Yan Z, Zou S, et al
    Identification of thermostability-enhancing mutations in H9N2 avian influenza virus hemagglutinin.
    J Virol. 2026 Mar 16:e0016826. doi: 10.1128/jvi.00168.
    >> Share

  66. FIELD CJ, Septer KM, Patel DR, Weaver VC, et al
    Defining the transmissible dose 50% for two pandemic influenza viruses in ferrets.
    J Virol. 2026 Mar 11:e0163525. doi: 10.1128/jvi.01635.
    >> Share

  67. LI S, Liu DX
    Interaction of coronavirus E protein with BRD2 plays important regulatory roles in viral replication and induction of pro-inflammatory response.
    J Virol. 2026 Mar 3:e0220125. doi: 10.1128/jvi.02201.
    >> Share

    February 2026
  68. NOORUZZAMAN M, Butt SL, Rani R, Ye C, et al
    The ORF6 accessory protein contributes to SARS-CoV-2 virulence and pathogenicity in the naturally susceptible feline model of infection.
    J Virol. 2026 Feb 27:e0064425. doi: 10.1128/jvi.00644.
    >> Share

  69. NAKANO T, Esaki M, Inoue A, Koike F, et al
    Impact of an amino acid deletion detected in the hemagglutinin (HA) antigenic site of swine influenza A virus field strains on HA antigenicity.
    J Virol. 2026 Feb 19:e0182025. doi: 10.1128/jvi.01820.
    >> Share

  70. LEYSON CM, Vargas-Maldonado N, Gaddy M, Raghunathan V, et al
    Viral lineage and mode of exposure modulate within-host spatial dynamics of influenza A viruses in a guinea pig model.
    J Virol. 2026 Feb 12:e0188925. doi: 10.1128/jvi.01889.
    >> Share

    January 2026
  71. YAO Q, Mahase V, Hou W, Cruz-Cosme R, et al
    Computational and experimental identification of potential neutralizing peptides derived from human ACE2 against SARS-CoV-2 infection.
    J Virol. 2026 Jan 30:e0146825. doi: 10.1128/jvi.01468.
    >> Share

  72. BRIGLEB PH, Sharp B, Lazure L, Livingston B, et al
    Immune history confers antibody- and T cell-dependent cross-protection against highly pathogenic avian influenza H5N1 viruses.
    J Virol. 2026 Jan 22:e0208825. doi: 10.1128/jvi.02088.
    >> Share

  73. TIEN C-F, Lin E-J, Tsai W-H, Tsai W-T, et al
    SARS-CoV-2 spike protein expression drives post-acute coagulopathy.
    J Virol. 2026 Jan 21:e0125525. doi: 10.1128/jvi.01255.
    >> Share

  74. YANG Q, Xue B, Qiu X, Yang K, et al
    Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC.
    J Virol. 2026;100:e0148725.
    >> Share

  75. ALVARADO RE, Lokugamage KG, Garvanska D, Estes LK, et al
    Key residues in SARS-CoV-2 NSP3 hypervariable region are necessary to modulate early stress granule activity.
    J Virol. 2026 Jan 14:e0200625. doi: 10.1128/jvi.02006.
    >> Share

  76. CONG G, Li H, Li L, Chen J, et al
    The newly developed porcine-origin parainfluenza virus PIV5-JS17 serves as an exogenous gene delivery system for swine.
    J Virol. 2026 Jan 13:e0185825. doi: 10.1128/jvi.01858.
    >> Share

  77. DALY RE, Feng CY, Hesser CR, Myasnikov I, et al
    N-terminal acetylation controls multiple functional aspects of the influenza A virus ribonuclease PA-X.
    J Virol. 2026 Jan 9:e0199925. doi: 10.1128/jvi.01999.
    >> Share

  78. MASTERS PS
    Coronavirus genome packaging and nucleocapsid assembly.
    J Virol. 2026 Jan 8:e0133025. doi: 10.1128/jvi.01330.
    >> Share

  79. PRASAI K, Yang Z, Guan M, Li T, et al
    Intrahost HA polymorphisms and culture adaptation shape antigenic profiles of H3N2 influenza viruses.
    J Virol. 2026 Jan 7:e0177525. doi: 10.1128/jvi.01775.
    >> Share

  80. HAZELL NC, Reyna RA, Adam A, Bonam SR, et al
    mRNA-delivered neutralizing antibodies confer protection against SARS-CoV-2 in animal models.
    J Virol. 2026 Jan 7:e0189725. doi: 10.1128/jvi.01897.
    >> Share

  81. BI Z
    Adaptation differences and mechanisms of influenza viruses to ANP32 proteins across species.
    J Virol. 2026 Jan 5:e0190025. doi: 10.1128/jvi.01900.
    >> Share

    December 2025
  82. ZHAO Y, Ma Q, Jiao C, Liu J, et al
    Recombinant duck enteritis virus harboring the hemagglutinin genes of influenza virus rapidly induces specific cellular immunity in ducks.
    J Virol. 2025 Dec 30:e0201425. doi: 10.1128/jvi.02014.
    >> Share

  83. DIEGO JG-B, Arranz-Herrero J, Laghlali G, Burgess E, et al
    Disease modulation by TIV vaccination during secondary pneumococcal infections in influenza-infected mice.
    J Virol. 2025 Dec 29:e0177425. doi: 10.1128/jvi.01774.
    >> Share

  84. SCHMIERER J, Lutz M, Takimoto T
    Enhanced genome replication activity of pandemic H1N1 influenza A virus through PA mutations.
    J Virol. 2025 Dec 23:e0139125. doi: 10.1128/jvi.01391.
    >> Share

  85. ZHANG M, Qin L, Guo R, Li J, et al
    A novel bispecific nanobody protects mice against RSV infection via intranasal administration.
    J Virol. 2025;99:e0128525.
    >> Share

  86. FONSECA BF, Robinot R, Michel V, Mendez A, et al
    Stealth replication of SARS-CoV-2 Omicron in the nasal epithelium at physiological temperature.
    J Virol. 2025 Dec 19:e0200825. doi: 10.1128/jvi.02008.
    >> Share

  87. HAWKINS GM, Qing E, Salgado J, Chan P, et al
    A murine coronavirus infection platform identifies proviral and proinflammatory activities of SARS-CoV-2 accessory protein 7a.
    J Virol. 2025 Dec 16:e0196124. doi: 10.1128/jvi.01961.
    >> Share

  88. KAR J, Hirohama M, Nakayama K, Lee S, et al
    Microtubule detyrosination links inflammasome activation to apoptotic cell death in macrophages upon influenza A virus infection.
    J Virol. 2025 Dec 9:e0184725. doi: 10.1128/jvi.01847.
    >> Share

  89. AHMETAJ-SHALA B, Peacock TP, Baillon L, Swann OC, et al
    Resistance of endothelial cells to SARS-CoV-2 infection in vitro.
    J Virol. 2025 Dec 5:e0120525. doi: 10.1128/jvi.01205.
    >> Share

  90. KUSAKARI D, Kishimoto N, Oshiro K, Udeda Y, et al
    Targeting envelope lipids with 2,6?di?O?methyl?3?acetyl?beta?cyclodextrin impairs infectivity of SARS?CoV?2 and Japanese encephalitis virus.
    J Virol. 2025 Dec 4:e0135725. doi: 10.1128/jvi.01357.
    >> Share

    November 2025
  91. HUANG J, Xu S, Liu J, Wang Q, et al
    The viral proteins of influenza A virus competitively bind to TRIM31 with MAVS to fine-tune the antiviral innate immunity.
    J Virol. 2025 Nov 26:e0189325. doi: 10.1128/jvi.01893.
    >> Share

  92. SAUL S, Dahal B, Luongo C, Liu X, et al
    Intranasal bovine/human parainfluenza virus 3 vaccine candidates expressing human metapneumovirus wild-type or pre-fusion F protein elicit protective immunity against human metapneumovirus in hamsters.
    J Virol. 2025 Nov 25:e0114525. doi: 10.1128/jvi.01145.
    >> Share

  93. SHEN W, Xu J, Chen Z, Wei Y, et al
    Broad-spectrum inhibition of influenza A virus replication by blocking the nuclear export of viral ribonucleoprotein complexes.
    J Virol. 2025 Nov 25:e0147825. doi: 10.1128/jvi.01478.
    >> Share

  94. YU W, He X, Zhao J, Dou Y, et al
    Direct airway delivery of a humanized anti-H7N9 neutralizing antibody broadly protects against divergent H7 influenza viruses in the mouse model.
    J Virol. 2025 Nov 24:e0132725. doi: 10.1128/jvi.01327.
    >> Share

  95. JIN Q, Liu R, Wang W, Xie J, et al
    Increased pathogenicity and transmission of SARS-CoV-2 Omicron XBB.1.9 subvariants, including HK.3 and EG.5.1, relative to BA.2.
    J Virol. 2025 Nov 18:e0134225. doi: 10.1128/jvi.01342.
    >> Share

  96. YUAN S, Wang J, Sang X, Xie Y, et al
    Structure-guided discovery of a small molecule inhibitor of SARS-CoV-2 main protease with potent in vitro and in vivo antiviral activities.
    J Virol. 2025 Nov 14:e0100125. doi: 10.1128/jvi.01001.
    >> Share

  97. NAITO T, Ushirogawa H, Kunishio M, Yano H, et al
    Live-attenuated influenza virus vaccine strain with an engineered temperature-sensitive and genetically stable viral polymerase variant.
    J Virol. 2025 Nov 13:e0139025. doi: 10.1128/jvi.01390.
    >> Share

  98. MUTHURAMAN K, Jackman M, Liang Y, Garrett ME, et al
    Human antibody targeting of coronavirus spike S2 subunit is associated with protection mediated by Fc effector functions.
    J Virol. 2025 Nov 12:e0152325. doi: 10.1128/jvi.01523.
    >> Share

  99. JUNG KI, Xia C, McKenna S, He Y, et al
    Ceramide synthase 4 interferes with replication of influenza virus but is downregulated by infection.
    J Virol. 2025 Nov 11:e0156325. doi: 10.1128/jvi.01563.
    >> Share

  100. ZHAO M, Zhang Y, Liang Y, Lei F, et al
    SARS-CoV-2 polyprotein expression and the induction of double-membrane vesicles.
    J Virol. 2025 Nov 6:e0138525. doi: 10.1128/jvi.01385.
    >> Share

  101. POWERS JM, Leist SR, Suryadevara N, Zost SJ, et al
    Mouse-adapted SARS-CoV-2 Omicron BA.5 infection induces post-acute lung fibrosis in BALB/c mice.
    J Virol. 2025 Nov 6:e0140625. doi: 10.1128/jvi.01406.
    >> Share

  102. IRELAND J, Myers D, Huang C, Allen C, et al
    Vaccination protects against COVID-associated pulmonary fibrin deposition.
    J Virol. 2025 Nov 6:e0063325. doi: 10.1128/jvi.00633.
    >> Share

  103. CHANG LA, Yeung ST, Warang P, Noureddine M, et al
    Transient lung eosinophilia during breakthrough influenza infection in vaccinated mice is associated with protective and balanced Type 1/2 immune responses.
    J Virol. 2025 Nov 5:e0096525. doi: 10.1128/jvi.00965.
    >> Share

  104. PAGE CK, Mubassir MHM, Chopra P, Gay LC, et al
    N-glycosylation at the receptor binding site drives differences in receptor binding specificity between influenza B virus lineages.
    J Virol. 2025 Nov 5:e0103925. doi: 10.1128/jvi.01039.
    >> Share

  105. LIN M-W, Quintela IA, Sablani SS, Lin C-S, et al
    Recent advances in lateral flow devices and point-of-care diagnostics for highly pathogenic avian influenza A viruses.
    J Virol. 2025 Nov 4:e0148425. doi: 10.1128/jvi.01484.
    >> Share

  106. WANG C, Shuai L, Zhong G, Wen Z, et al
    Transmission of SARS-CoV-2 between ferrets in presence of pre-existing immunity.
    J Virol. 2025 Nov 4:e0156625. doi: 10.1128/jvi.01566.
    >> Share

    October 2025
  107. LEI H, Xiao B, Lin X, Liang Z, et al
    Chronology of H3N2 human influenza virus surface glycoprotein adaptation from 1968 to 2019 reveals a surge of adaptation between 1997 and 2002.
    J Virol. 2025 Oct 31:e0132925. doi: 10.1128/jvi.01329.
    >> Share

  108. JOHNSON KEE, Stein S, Boateng RA, Jain S, et al
    Tissue tropism and functional adaptation of the SARS-CoV-2 spike protein in a fatal case of COVID-19.
    J Virol. 2025 Oct 31:e0085725. doi: 10.1128/jvi.00857.
    >> Share

  109. DETTE A, Moers F, Mayr T, Stillfried Sv, et al
    Differential expression of viral entry protein neuropilin 1 (NRP1) and neuropilin 2 (NRP2) in fatal COVID-19.
    J Virol. 2025 Oct 29:e0138425. doi: 10.1128/jvi.01384.
    >> Share

  110. SHU T, Wang X, Li Y, Su J, et al
    Respiratory syncytial virus phosphoprotein has NTPase and helicase-like activities.
    J Virol. 2025;99:e0099625.
    >> Share

  111. RZYMSKI P, Poniedzialek B, Zarebska-Michaluk D, Tomasiewicz K, et al
    High seroprevalence and high risk: why are older adults more prone to respiratory syncytial virus?
    J Virol. 2025;99:e0143225.
    >> Share

  112. DING S, Yang D, Ullah I, Niu L, et al
    Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variants.
    J Virol. 2025 Oct 13:e0103425. doi: 10.1128/jvi.01034.
    >> Share

  113. DADONAITE B, Harari S, Larsen BB, Kampman L, et al
    Spike mutations that affect the function and antigenicity of recent KP.3.1.1-like SARS-CoV-2 variants.
    J Virol. 2025 Oct 13:e0142325. doi: 10.1128/jvi.01423.
    >> Share

  114. WANG W, Du P, Zhao Y, Liang Y, et al
    Biomimetic nanovaccines with self-adjuvant effects induced broad-spectrum neutralizing antibodies against SARS-CoV-2 infection in rodents.
    J Virol. 2025 Oct 10:e0031525. doi: 10.1128/jvi.00315.
    >> Share

  115. MITCHELL JK, Mastrodomenico V, Hartnett J, Heelan WJ, et al
    A HiBiT-tagged pseudovirus-like particle platform for safe, rapid quantification of virus neutralization and antibody-dependent enhancement.
    J Virol. 2025 Oct 8:e0099125. doi: 10.1128/jvi.00991.
    >> Share

  116. SHETTY N, Shephard MJ, Rockey NC, Macenczak H, et al
    Correction for Shetty et al., "Influenza virus infection and aerosol shedding kinetics in a controlled human infection model".
    J Virol. 2025 Oct 7:e0135425. doi: 10.1128/jvi.01354.
    >> Share

  117. PAN Z, Jiang L, Chen Y, Peng H, et al
    Adjuvant-dependent protection of SARS-CoV-2 spike vaccines: comparative immunogenicity of human-applicable formulations.
    J Virol. 2025 Oct 3:e0109925. doi: 10.1128/jvi.01099.
    >> Share

  118. BAMUNUARACHCHI G, Vaddadi K, Liang Y, Zhu Z, et al
    Tankyrases positively regulate influenza A virus replication via type I interferon response.
    J Virol. 2025 Oct 2:e0129825. doi: 10.1128/jvi.01298.
    >> Share

    September 2025
  119. SUN L, Huang M, Feng S, Zhang W, et al
    Developing an eVLP mRNA vaccine for respiratory syncytial virus with enhanced pre-fusion targeting humoral responses.
    J Virol. 2025 Sep 30:e0120925. doi: 10.1128/jvi.01209.
    >> Share

  120. ZHU B, Fung K, Feng HH, Beatty JA, et al
    The hemagglutinin proteins of clades 1 and 2.3.4.4b H5N1 highly pathogenic avian influenza viruses exhibit comparable attachment patterns to avian and mammalian tissues.
    J Virol. 2025 Sep 23:e0097625. doi: 10.1128/jvi.00976.
    >> Share

  121. JANZEN GM, Inderski BT, Chang J, Arendsee ZW, et al
    Sources and sinks of influenza A virus genomic diversity in swine from 2009 to 2022 in the United States.
    J Virol. 2025;99:e0054125.
    >> Share

  122. BATY JJ, Drozdick AK, Pfeiffer JK
    Pseudomonas aeruginosa rhamnolipids stabilize human rhinovirus 14 virions.
    J Virol. 2025;99:e0093125.
    >> Share

  123. TSUJINO S, Tsuda M, Nao N, Okumura K, et al
    Evolution of BA.2.86 to JN.1 reveals that functional changes in non-structural viral proteins are required for fitness of SARS-CoV-2.
    J Virol. 2025 Sep 23:e0090825. doi: 10.1128/jvi.00908.
    >> Share

  124. HAMMER E, Flynn C, Rossler J, Erder J, et al
    Prediction of COVID-19 disease progression by multiparametric analysis of circulating extracellular vesicles with flow cytometry.
    J Virol. 2025 Sep 23:e0118925. doi: 10.1128/jvi.01189.
    >> Share

  125. CHIOK KL, Jenik K, Fenton M, Falzarano D, et al
    MERS-CoV and SARS-CoV-2 infection in diverse human lung organoid-derived cultures.
    J Virol. 2025 Sep 18:e0109825. doi: 10.1128/jvi.01098.
    >> Share

  126. PAPPAS C, Brock N, Belser JA, Kieran TJ, et al
    Identification of clinical and virological correlates associated with influenza A candidate vaccine virus (CVV) attenuation in a ferret model.
    J Virol. 2025 Sep 17:e0102325. doi: 10.1128/jvi.01023.
    >> Share

  127. FARRUKEE R, Mordant F, Mackenzie-Kludas C, Mesner D, et al
    Human guanylate-binding protein (GBP) 1 inhibits replication of severe acute respiratory syndrome coronavirus 2.
    J Virol. 2025 Sep 15:e0082325. doi: 10.1128/jvi.00823.
    >> Share

  128. WANG J, Sang X, Zheng W, Chan JF-W, et al
    Discovery of a potent covalent inhibitor that unusually distorts the catalytic dyad of SARS-CoV-2 main protease.
    J Virol. 2025 Sep 15:e0065825. doi: 10.1128/jvi.00658.
    >> Share

  129. FAN W, Zeng X, Chen Y, Yu Q, et al
    A recombinant Marek's disease vaccine candidate provides complete protection against infectious bursal disease virus and H9 subtype avian influenza virus in chickens.
    J Virol. 2025 Sep 11:e0114925. doi: 10.1128/jvi.01149.
    >> Share

  130. LAN R, Yang J, Li J, Li H, et al
    Continuous evolution of Eurasian avian-like H1N1 swine influenza viruses with pdm/09-derived internal genes enhances pathogenicity in mice.
    J Virol. 2025 Sep 8:e0043025. doi: 10.1128/jvi.00430.
    >> Share

  131. NAKANO M, Miyamoto S, Ohnishi C, Nogami C, et al
    Influenza A virus circumvents the innate immune response through the sequestration of double-stranded RNA.
    J Virol. 2025 Sep 8:e0073725. doi: 10.1128/jvi.00737.
    >> Share

  132. JOSEPH R, Marais G, Iranzadeh I, Alisoltani A, et al
    Intra-host SARS-CoV-2 diversity in immunocompromised people living with HIV provides insight into the evolutionary trajectory of SARS-CoV-2.
    J Virol. 2025 Sep 5:e0078025. doi: 10.1128/jvi.00780.
    >> Share

  133. GRACIE NP, Aggarwal A, Luo R, Spicer M, et al
    An RGD motif on SARS-CoV-2 Spike induces TGF-beta signaling and downregulates interferon.
    J Virol. 2025 Sep 4:e0043525. doi: 10.1128/jvi.00435.
    >> Share

    August 2025
  134. GUO Z, Banas VS, He Y, Weiland E, et al
    Ciliated cells promote high infectious potential of influenza A virus through the efficient intracellular activation of hemagglutinin.
    J Virol. 2025 Aug 29:e0068525. doi: 10.1128/jvi.00685.
    >> Share

  135. VERMA A, Kamboj H, Kumar G, Khandelwal N, et al
    TGF-beta inhibitor SB431542 suppresses SARS-CoV-2 replication through multistep inhibition.
    J Virol. 2025 Aug 29:e0052925. doi: 10.1128/jvi.00529.
    >> Share

  136. GUO Y, Shu S, Zhou Y, Peng W, et al
    An emerging PB2-627 polymorphism increases the zoonotic risk of avian influenza virus by overcoming ANP32 host restriction in mammalian and avian hosts.
    J Virol. 2025 Aug 27:e0085325. doi: 10.1128/jvi.00853.
    >> Share

  137. HU Z, Tian S, Zhou Y, Wang Y, et al
    Nanoparticle vaccine based on the pre-fusion F glycoprotein of respiratory syncytial virus elicits robust protective immune responses.
    J Virol. 2025 Aug 26:e0090325. doi: 10.1128/jvi.00903.
    >> Share

  138. ROBINSON-MCCARTHY LR, Simmons HC, Graber AL, Marble CN, et al
    Dairy cattle herds mount a characteristic antibody response to highly pathogenic H5N1 avian influenza viruses.
    J Virol. 2025 Aug 25:e0062125. doi: 10.1128/jvi.00621.
    >> Share

  139. CHI X, Liang X, Vaddadi K, Zhang X, et al
    SARS-CoV-2 Nsp15 endoribonuclease subverts host defenses to enhance viral fitness in lung cells.
    J Virol. 2025 Aug 21:e0117525. doi: 10.1128/jvi.01175.
    >> Share

  140. ZHANG H, Deng X, Dai R, Fu J, et al
    Inadequate immune response to inactivated COVID-19 vaccine among older people living with HIV: a prospective cohort study.
    J Virol. 2025 Aug 21:e0068825. doi: 10.1128/jvi.00688.
    >> Share

  141. EL ZOWALATY ME, Taylor LJ, Son Y, Lee H, et al
    Discovery, phylogenetic, and comparative genomic analysis of novel avian gammacoronaviruses identified in feral pigeons (Columba livia domestica).
    J Virol. 2025 Aug 20:e0111225. doi: 10.1128/jvi.01112.
    >> Share

  142. HU J, Zheng H, Ran W, Wang X, et al
    Mucosal vaccination with long-form TSLP induces migratory cDC1-mediated adaptive immunity against SARS-CoV-2 infection.
    J Virol. 2025 Aug 19:e0123125. doi: 10.1128/jvi.01231.
    >> Share

  143. SAEIDI S, Wan H, Kang H, Gao J, et al
    N-linked glycans on the stalk of influenza virus neuraminidase promote functional tetramer formation by compensating for local hydrophobicity.
    J Virol. 2025 Aug 18:e0087925. doi: 10.1128/jvi.00879.
    >> Share

  144. DZIMIANSKI JV, Nagashima KA, Cruz JM, Sautto GA, et al
    Assessing the structural boundaries of broadly reactive antibody interactions with diverse H3 influenza hemagglutinin proteins.
    J Virol. 2025 Aug 14:e0045325. doi: 10.1128/jvi.00453.
    >> Share

  145. KELVIN AA, Baker PH, Ghosh S, Schultz-Cherry S, et al
    Influenza infection of the mammary gland.
    J Virol. 2025 Aug 12:e0194024. doi: 10.1128/jvi.01940.
    >> Share

  146. YAN Y, Xu J, Chen Z, Xu Y, et al
    Heat shock protein A1L restricts influenza A virus by ubiquitination of NA.
    J Virol. 2025 Aug 11:e0077125. doi: 10.1128/jvi.00771.
    >> Share

  147. KARIMI A, Lieber CM, Sakamoto K, Plemper RK, et al
    SARS-CoV-2 causes chronic lung inflammation and impaired respiratory capacity in aged Roborovski dwarf hamsters.
    J Virol. 2025 Aug 11:e0075525. doi: 10.1128/jvi.00755.
    >> Share

  148. ZANIN M, Flerlage T, Wong S-S, Vogel P, et al
    Inflammatory, transcriptomic, and cell fate responses underlying the mammalian transmission of avian influenza viruses.
    J Virol. 2025 Aug 8:e0064725. doi: 10.1128/jvi.00647.
    >> Share

  149. SOWNTHIRARAJAN B, Mason M, Loganathan G, Manivasagam S, et al
    A versatile H5N1-VSV platform for safe influenza virus research applications.
    J Virol. 2025 Aug 8:e0097525. doi: 10.1128/jvi.00975.
    >> Share

  150. MA Y, Ye C, Khalil AM, Mahmoud SH, et al
    A luminescent attenuated SARS-CoV-2 for the identification and validation of drug-resistant mutants.
    J Virol. 2025 Aug 7:e0082125. doi: 10.1128/jvi.00821.
    >> Share

  151. LIU Z, Zhang L, Zhang W, Lai Y, et al
    The 5'-end segment-specific noncoding region of influenza A virus regulates both competitive multi-segment RNA transcription and selective genome packaging during infection.
    J Virol. 2025 Aug 5:e0032825. doi: 10.1128/jvi.00328.
    >> Share

  152. MBOKO WP, Wang Y, Cao W, Sayedahmed EE, et al
    Trained ILCs confer adaptive immunity-independent protection against influenza.
    J Virol. 2025 Aug 4:e0053225. doi: 10.1128/jvi.00532.
    >> Share

    July 2025
  153. MANNSVERK S, Villamil Giraldo AM, Kasson PM
    Influenza viral infection at the plasma membrane is restricted by lipid composition.
    J Virol. 2025 Jul 24:e0110525. doi: 10.1128/jvi.01105.
    >> Share

  154. LI Q, Cai X, Li X, Zhang Y, et al
    Structural and functional constraints on spike activation and host protease utilization limit cell entry of SARS-CoV-2-related bat coronaviruses.
    J Virol. 2025 Jul 24:e0100725. doi: 10.1128/jvi.01007.
    >> Share

  155. SIMONICH CAL, McMahon TE, Ju X, Yu TC, et al
    RSV F evolution escapes some monoclonal antibodies but does not strongly erode neutralization by human polyclonal sera.
    J Virol. 2025;99:e0053125.
    >> Share

  156. ZHANG J, Li M, Cheng J, Wang Y, et al
    CypA inhibits respiratory syncytial virus (RSV) replication by suppressing glycolysis through the downregulation of PKM2 expression.
    J Virol. 2025;99:e0007425.
    >> Share

  157. KALIN JH, Yin Y, Tran MT, Piassek M, et al
    Discovery of a non-nucleoside inhibitor that binds to a novel site in the palm domain of the respiratory syncytial virus RNA-dependent RNA polymerase.
    J Virol. 2025;99:e0017825.
    >> Share

  158. LEONARD RA, Spurrier MA, Skavicus S, Luo Z, et al
    Development of DNA and mRNA-LNP vaccines against an H5N1 clade 2.3.4.4b influenza virus.
    J Virol. 2025 Jul 16:e0079525. doi: 10.1128/jvi.00795.
    >> Share

  159. CARLOCK MA, Pierce SR, Ross TM
    Breadth of antibody activity elicited by an influenza B hemagglutinin vaccine is influenced by pre-existing immune responses to influenza B viruses.
    J Virol. 2025 Jul 15:e0070525. doi: 10.1128/jvi.00705.
    >> Share

  160. XU Z, Li L, Gu Y, Li D, et al
    CX1/BtSY2 and BANAL-20-52 exhibit broader receptor binding and higher affinities to multiple animal ACE2 orthologs than SARS-CoV-2 prototype.
    J Virol. 2025 Jul 10:e0028325. doi: 10.1128/jvi.00283.
    >> Share

  161. KANDEL S, Babujee L, Guan L, Dahn R, et al
    Phylogenetic analysis of H5N1 influenza viruses isolated from dairy cattle in Texas in December 2024.
    J Virol. 2025 Jul 8:e0058025. doi: 10.1128/jvi.00580.
    >> Share

    June 2025
  162. CHEN PR, White SN, Walker LR, Kapczynski DR, et al
    Genetic resilience or resistance in poultry against avian influenza virus: mirage or reality?
    J Virol. 2025 Jun 30:e0082025. doi: 10.1128/jvi.00820.
    >> Share

  163. POWELL BH, Witwer KW, Meffert MK
    Cellular miRNAs and viruses: trends in miRNA sequestering and target de-repression.
    J Virol. 2025 Jun 18:e0091425. doi: 10.1128/jvi.00914.
    >> Share

  164. CHEN Y, Shi Y, Zuo X, Dong X, et al
    UNC0638 inhibits SARS-CoV-2 entry by blocking cathepsin L maturation.
    J Virol. 2025 Jun 18:e0074125. doi: 10.1128/jvi.00741.
    >> Share

  165. ESPARZA M, El Zahed SS, Karakus U, Niederstrasser H, et al
    Contrasting interferon-mediated antiviral responses in human lung adenocarcinoma cells.
    J Virol. 2025;99:e0046925.
    >> Share

  166. SONG Q, Yang H, Zhu H, Hu Y, et al
    Hydrophobic residue substitutions enhance the stability and in vivo immunogenicity of respiratory syncytial virus fusion protein.
    J Virol. 2025;99:e0008725.
    >> Share

  167. JONES JE, Lakdawala SS
    Host origin is a determinant of coevolution between gene segments of avian H9 influenza viruses.
    J Virol. 2025 Jun 13:e0151824. doi: 10.1128/jvi.01518.
    >> Share

  168. HARRIS C, Kapingidza AB, San JE, Christopher J, et al
    Design of SARS-CoV-2 RBD immunogens to focus immune responses toward conserved coronavirus epitopes.
    J Virol. 2025 Jun 13:e0046525. doi: 10.1128/jvi.00465.
    >> Share

  169. LV H, Teo QW, Lee C-CD, Liang W, et al
    Correction for Lv et al., "Differential antigenic imprinting effects between influenza H1N1 hemagglutinin and neuraminidase in a mouse model".
    J Virol. 2025 Jun 12:e0078325. doi: 10.1128/jvi.00783.
    >> Share

  170. LOKUGAMAGE KG, Zhou Y, Alvarado RE, Plante JA, et al
    Convergent evolution in nucleocapsid facilitated SARS-CoV-2 adaptation for human infection.
    J Virol. 2025 Jun 12:e0209124. doi: 10.1128/jvi.02091.
    >> Share

  171. COTTIGNIES-CALAMARTE A, Marteau F, He F, Belouzard S, et al
    Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy flux and the type I IFN response.
    J Virol. 2025 Jun 12:e0039425. doi: 10.1128/jvi.00394.
    >> Share

  172. SULLIVAN OM, Nesbitt DJ, Schaack GA, Feltman EM, et al
    IFIT3 RNA-binding activity promotes influenza A virus infection and translation efficiency.
    J Virol. 2025 Jun 11:e0028625. doi: 10.1128/jvi.00286.
    >> Share

  173. MORGAN AL, Vu MN, Zhou Y, Lokugamage KG, et al
    The furin cleavage site is required for pathogenesis, but not transmission, of SARS-CoV-2.
    J Virol. 2025 Jun 10:e0046725. doi: 10.1128/jvi.00467.
    >> Share

  174. FOSTER CSP, Walker GJ, Jean T, Wong M, et al
    Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution.
    J Virol. 2025 Jun 9:e0036325. doi: 10.1128/jvi.00363.
    >> Share

  175. COGGON A, Lopes S, Simon G, Arendsee Z, et al
    Quantifying the zoonotic risk profile of European influenza A viruses in swine from 2010 to 2020 inclusive.
    J Virol. 2025 Jun 4:e0030625. doi: 10.1128/jvi.00306.
    >> Share

  176. ROBINSON-MCCARTHY LR, Zirckel KE, Simmons HC, Le Sage V, et al
    A replicating recombinant vesicular stomatitis virus model for dairy cattle H5N1 influenza virus glycoprotein evolution.
    J Virol. 2025 Jun 4:e0038925. doi: 10.1128/jvi.00389.
    >> Share

  177. NGUYEN D, Laidlaw SM, Dong X, Wand M, et al
    SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management.
    J Virol. 2025 Jun 4:e0051925. doi: 10.1128/jvi.00519.
    >> Share

  178. SEIBERT B, Caceres CJ, Gay LC, Shetty N, et al
    Air-liquid interface model for influenza aerosol exposure in vitro.
    J Virol. 2025 Jun 3:e0061925. doi: 10.1128/jvi.00619.
    >> Share

    May 2025
  179. ZHANG Q, Zhang L, Li J, Zhang W, et al
    hnRNPM regulates influenza A virus replication through distinct mechanisms in human and avian cells: implications for cross-species transmission.
    J Virol. 2025 May 28:e0006725. doi: 10.1128/jvi.00067.
    >> Share

  180. BEAN DJ, Liang YM, Avila F, He X, et al
    Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding antibodies.
    J Virol. 2025 May 19:e0055025. doi: 10.1128/jvi.00550.
    >> Share

  181. KOUTSAKOS M, Reynaldi A, Aban M, Barr IG, et al
    Binding antibody titers against the hemagglutinin and neuraminidase correlate with protection against medically attended influenza A and B disease.
    J Virol. 2025 May 13:e0039125. doi: 10.1128/jvi.00391.
    >> Share

  182. FURUSAWA Y, Iwatsuki-Horimoto K, Yamayoshi S, Kawaoka Y, et al
    The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduced viral polymerase activity caused by mutations in NSP13 and NSP14.
    J Virol. 2025 May 13:e0065625. doi: 10.1128/jvi.00656.
    >> Share

  183. KONDO T, Suzuki R, Yajima H, Kawahara S, et al
    Determinants of susceptibility to SARS-CoV-2 infection in murine ACE2.
    J Virol. 2025 May 12:e0054325. doi: 10.1128/jvi.00543.
    >> Share

  184. XIE Z, Yang J, Jiao W, Li X, et al
    Clade 2.3.4.4b highly pathogenic avian influenza H5N1 viruses: knowns, unknowns, and challenges.
    J Virol. 2025 May 9:e0042425. doi: 10.1128/jvi.00424.
    >> Share

  185. LI Y, Quan X, Chen R, Wang X, et al
    Adaptive selection of quasispecies during in vivo passaging in chickens, mice, and ferrets results in host-specific strains for the H9N2 avian influenza virus.
    J Virol. 2025 May 8:e0015125. doi: 10.1128/jvi.00151.
    >> Share

  186. LUGANO D, Mwangi K, Mware B, Kibet G, et al
    Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population.
    J Virol. 2025 May 6:e0048225. doi: 10.1128/jvi.00482.
    >> Share

    April 2025
  187. ZHANG S, Xu C-L, Wang J, Xiong X, et al
    Spike proteins of coronaviruses activate mast cells for degranulation via stimulating Src/PI3K/AKT/Ca(2+) intracellular signaling cascade.
    J Virol. 2025 Apr 30:e0007825. doi: 10.1128/jvi.00078.
    >> Share

  188. NEGI V, Kuhn RJ
    A BSL-2 chimeric system designed to screen SARS-CoV-2 E protein ion channel inhibitors.
    J Virol. 2025 Apr 30:e0225224. doi: 10.1128/jvi.02252.
    >> Share

  189. SUN H, Yang Q, Zhang Y, Cui S, et al
    Syntaxin-6 restricts SARS-CoV-2 infection by facilitating virus trafficking to autophagosomes.
    J Virol. 2025 Apr 25:e0000225. doi: 10.1128/jvi.00002.
    >> Share

  190. DE AVILA AI, Soria ME, Martinez-Gonzalez B, Somovilla P, et al
    SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues.
    J Virol. 2025 Apr 24:e0225024. doi: 10.1128/jvi.02250.
    >> Share

  191. LE CTT, Kim K-H, Raha JR, Bhatnagar N, et al
    Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination.
    J Virol. 2025 Apr 23:e0229424. doi: 10.1128/jvi.02294.
    >> Share

  192. LOWEN AC, Baker AL, Bowman AS, Garcia-Sastre A, et al
    Pandemic risk stemming from the bovine H5N1 outbreak: an account of the knowns and unknowns.
    J Virol. 2025;99:e0005225.
    >> Share

  193. KAWAKITA T, Sekiya T, Kameda Y, Nomura N, et al
    ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4(+) and CD8(+) T-cell responses and neutralizing antibody induction.
    J Virol. 2025 Apr 15:e0229024. doi: 10.1128/jvi.02290.
    >> Share

  194. ADU OF, Sempere Borau M, Fruh SP, Karakus U, et al
    Cell binding, uptake, and infection of influenza A virus using recombinant antibody-based receptors.
    J Virol. 2025 Apr 10:e0227524. doi: 10.1128/jvi.02275.
    >> Share

  195. ZHOU B, Gui Q, Liu C, Guo H, et al
    Structure and function of an unusual R452-dependent monoclonal antibody against SARS-CoV-2.
    J Virol. 2025 Apr 8:e0184424. doi: 10.1128/jvi.01844.
    >> Share

  196. XU S, Liu Y, Luo C, Zhou M, et al
    Identification and characterization of a broadly neutralizing and protective nanobody against the HA1 domain of H5 avian influenza virus hemagglutinin.
    J Virol. 2025 Apr 7:e0209024. doi: 10.1128/jvi.02090.
    >> Share

  197. XIAO X, Wang X, Xu F, Liang Y, et al
    Synergistic effects of PA (S184N) and PB2 (E627K) mutations on the increased pathogenicity of H3N2 canine influenza virus infections in mice and dogs.
    J Virol. 2025 Apr 4:e0198424. doi: 10.1128/jvi.01984.
    >> Share

  198. XIAO X, Li S, Zheng Z, Ji Y, et al
    Targeting USP22 to promote K63-linked ubiquitination and degradation of SARS-CoV-2 nucleocapsid protein.
    J Virol. 2025 Apr 4:e0223424. doi: 10.1128/jvi.02234.
    >> Share

    March 2025
  199. GHIMIRE R, Shrestha R, Amaradhi R, Liu L, et al
    Toll-like receptor 7 (TLR7)-mediated antiviral response protects mice from lethal SARS-CoV-2 infection.
    J Virol. 2025 Mar 31:e0166824. doi: 10.1128/jvi.01668.
    >> Share

  200. NOETTGER S, Zech F, Nchioua R, Pastorio C, et al
    Role of N-linked glycosylation sites in human ACE2 in SARS-CoV-2 and hCoV-NL63 infection.
    J Virol. 2025 Mar 28:e0220224. doi: 10.1128/jvi.02202.
    >> Share

  201. KRAMMER F, Hermann E, Rasmussen AL
    Highly pathogenic avian influenza H5N1: history, current situation, and outlook.
    J Virol. 2025 Mar 27:e0220924. doi: 10.1128/jvi.02209.
    >> Share

  202. YU L, Jiang Y, Rang H, Wang X, et al
    Restriction of influenza A virus replication by host DCAF7-CRL4B axis.
    J Virol. 2025 Mar 27:e0013325. doi: 10.1128/jvi.00133.
    >> Share

  203. JANA ID, Kanjo K, Roy S, Bhasin M, et al
    Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants.
    J Virol. 2025 Mar 26:e0005125. doi: 10.1128/jvi.00051.
    >> Share

  204. LI P, Faraone JN, Hsu CC, Chamblee M, et al
    Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability.
    J Virol. 2025 Mar 26:e0024225. doi: 10.1128/jvi.00242.
    >> Share

  205. LANG Y, Shi L, Roy S, Gupta D, et al
    Detection of antibodies against influenza A viruses in cattle.
    J Virol. 2025 Mar 25:e0213824. doi: 10.1128/jvi.02138.
    >> Share

  206. JOHN K, Huntress I, Smith E, Chou H, et al
    Human long noncoding RNA VILMIR is induced by major respiratory viral infections and modulates the host interferon response.
    J Virol. 2025 Mar 25:e0014125. doi: 10.1128/jvi.00141.
    >> Share

  207. DADONAITE B, Burrell AR, Logue J, Chu HY, et al
    SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals.
    J Virol. 2025 Mar 25:e0010925. doi: 10.1128/jvi.00109.
    >> Share

  208. BEAVIS AC, Xiao P, Gingerich MC, Briggs K, et al
    A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates.
    J Virol. 2025 Mar 21:e0199024. doi: 10.1128/jvi.01990.
    >> Share

  209. BEAVIS AC, Li Z, Briggs K, Gingerich MC, et al
    Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants.
    J Virol. 2025 Mar 21:e0198924. doi: 10.1128/jvi.01989.
    >> Share

  210. SIMS A, Weir DJ, Cole SJ, Hutchinson E, et al
    SARS-CoV-2 cellular coinfection is limited by superinfection exclusion.
    J Virol. 2025 Mar 21:e0207724. doi: 10.1128/jvi.02077.
    >> Share

  211. HU H, Zhang Y, Zheng H, Zhao X, et al
    Thymic stromal lymphopoietin improves protective immunity of the SARS-CoV-2 subunit vaccine by inducing dendritic cell-dependent germinal center response.
    J Virol. 2025 Mar 4:e0232324. doi: 10.1128/jvi.02323.
    >> Share

  212. KARL V, Hofmann M, Thimme R
    Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination.
    J Virol. 2025 Mar 3:e0135024. doi: 10.1128/jvi.01350.
    >> Share

    February 2025
  213. QU X, Zhu Z, Zhou X, Wu X, et al
    KRT9 is required for GBP5 suppression of human respiratory syncytial virus.
    J Virol. 2025;99:e0202924.
    >> Share

  214. MILLER JL, Leedale C, Kang D, Lilue J, et al
    Prostaglandin D2 delays CD8+ T-cell responses and respiratory syncytial virus clearance in geriatric cotton rats.
    J Virol. 2025;99:e0186324.
    >> Share

  215. HAO T, Xie Y, Chai Y, Zhang W, et al
    Structural basis of receptor-binding adaptation of human-infecting H3N8 influenza A virus.
    J Virol. 2025 Feb 24:e0106524. doi: 10.1128/jvi.01065.
    >> Share

  216. KOBAYASHI D, Hiono T, Arakawa H, Kaji H, et al
    Deglycosylation and truncation in the neuraminidase stalk are functionally equivalent in enhancing the pathogenicity of a high pathogenicity avian influenza virus in chickens.
    J Virol. 2025 Feb 14:e0147824. doi: 10.1128/jvi.01478.
    >> Share

  217. MA R, Zhang X, Li R, Dong X, et al
    PLSCR1 suppresses SARS-CoV-2 infection by downregulating cell surface ACE2.
    J Virol. 2025 Feb 13:e0208524. doi: 10.1128/jvi.02085.
    >> Share

  218. FURUSAWA Y, Kiso M, Uraki R, Sakai-Tagawa Y, et al
    Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures.
    J Virol. 2025 Feb 12:e0221724. doi: 10.1128/jvi.02217.
    >> Share

  219. KUHN AJ, Outlaw VK, Marcink TC, Yu Z, et al
    Enhancing the solubility of SARS-CoV-2 inhibitors to increase future prospects for clinical development.
    J Virol. 2025 Feb 4:e0215924. doi: 10.1128/jvi.02159.
    >> Share

  220. PHAN T, Ribeiro RM, Edelstein GE, Boucau J, et al
    Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance.
    J Virol. 2025 Feb 4:e0162324. doi: 10.1128/jvi.01623.
    >> Share

  221. WANG X, Dong M, Wu X, Schnepf D, et al
    Single-cell transcriptomics reveals a compartmentalized antiviral interferon response in the nasal epithelium of mice.
    J Virol. 2025 Feb 4:e0141324. doi: 10.1128/jvi.01413.
    >> Share

  222. PARK H, Kingstad-Bakke B, Cleven T, Jung M, et al
    Diversifying T-cell responses: safeguarding against pandemic influenza with mosaic nucleoprotein.
    J Virol. 2025 Feb 3:e0086724. doi: 10.1128/jvi.00867.
    >> Share

    January 2025
  223. KIRKPATRICK ROUBIDOUX E, Meliopoulos V, Livingston B, Brigleb PH, et al
    Intraductal infection with H5N1 clade 2.3.4.4b influenza virus.
    J Virol. 2025 Jan 31:e0192724. doi: 10.1128/jvi.01927.
    >> Share

  224. ZHAO B, Sun Z, Wang S, Shi Z, et al
    Structural basis of different neutralization capabilities of monoclonal antibodies against H7N9 virus.
    J Virol. 2025;99:e0140024.
    >> Share

  225. SAMAAN P, Korosec CS, Budylowski P, Chau SLL, et al
    mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-gamma and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity.
    J Virol. 2025 Jan 31:e0168524. doi: 10.1128/jvi.01685.
    >> Share

  226. LYTRAS S, Lamb KD, Ito J, Grove J, et al
    Pathogen genomic surveillance and the AI revolution.
    J Virol. 2025 Jan 29:e0160124. doi: 10.1128/jvi.01601.
    >> Share

  227. WANG Y, Xia B, Gao Z
    A comprehensive review of current insights into the virulence factors of SARS-CoV-2.
    J Virol. 2025 Jan 29:e0204924. doi: 10.1128/jvi.02049.
    >> Share

  228. SADLER HL, Rijal P, Tan TK, Townsend ARM, et al
    A locally administered single-cycle influenza vaccine expressing a non-fusogenic stabilized hemagglutinin stimulates strong T-cell and neutralizing antibody immunity.
    J Virol. 2025 Jan 27:e0033124. doi: 10.1128/jvi.00331.
    >> Share

  229. FOO IJH, Chua BY, Chang SY, Jia X, et al
    Prior influenza virus infection alleviates an arbovirus encephalitis by reducing viral titer, inflammation, and cellular infiltrates in the central nervous system.
    J Virol. 2025 Jan 16:e0210824. doi: 10.1128/jvi.02108.
    >> Share

  230. NAGHIBOSADAT M, Babuadze GG, Pei Y, Hurst J, et al
    Vaccination against SARS-CoV-2 provides low-level cross-protection against common cold coronaviruses in mouse and non-human primate animal models.
    J Virol. 2025 Jan 16:e0139024. doi: 10.1128/jvi.01390.
    >> Share

  231. CAI C, Pham TNQ, Adam D, Brochiero E, et al
    Sensing of SARS-CoV-2-infected cells by plasmacytoid dendritic cells is modulated via an interplay between CD54/ICAM-1 and CD11a/LFA-1 alpha(L) integrin.
    J Virol. 2025 Jan 13:e0123524. doi: 10.1128/jvi.01235.
    >> Share

  232. PERRY SS, Brice DC, Sakr AA, Kandeil A, et al
    Modulation of cytokeratin and cytokine/chemokine expression following influenza virus infection of differentiated human tonsillar epithelial cells.
    J Virol. 2025 Jan 10:e0146024. doi: 10.1128/jvi.01460.
    >> Share

  233. FOX CR, Yousef NN, Varudkar N, Shiffer EM, et al
    Resistance to complement-mediated lysis of parainfluenza virus 5-infected cells is acquired after transition from acute to persistent infection.
    J Virol. 2025 Jan 10:e0189524. doi: 10.1128/jvi.01895.
    >> Share

  234. ARORA P, Zhang L, Nehlmeier I, Kempf A, et al
    Host cell lectins ASGR1 and DC-SIGN jointly with TMEM106B confer ACE2 independence and imdevimab resistance to SARS-CoV-2 pseudovirus with spike mutation E484D.
    J Virol. 2025 Jan 10:e0123024. doi: 10.1128/jvi.01230.
    >> Share

  235. HU H, Leng C, Shu Y, Peng L, et al
    Structural insights into hybridoma-derived neutralizing monoclonal antibodies against Omicron BA.5 and XBB.1.16 variants of SARS-CoV-2.
    J Virol. 2025 Jan 7:e0130724. doi: 10.1128/jvi.01307.
    >> Share

  236. GUNAWARDENE CD, Wong L-YR
    Betacoronavirus internal protein: role in immune evasion and viral pathogenesis.
    J Virol. 2025 Jan 6:e0135324. doi: 10.1128/jvi.01353.
    >> Share

    December 2024
  237. CAI Z, Ni W, Li W, Wu Z, et al
    SARS-CoV-2 S protein disrupts the formation of ISGF3 complex through conserved S2 subunit to antagonize type I interferon response.
    J Virol. 2024 Dec 19:e0151624. doi: 10.1128/jvi.01516.
    >> Share

  238. XIONG Y, Tao K, Li T, Zhou Y, et al
    Both chebulagic acid and punicalagin inhibit respiratory syncytial virus entry via multi-targeting glycoprotein and fusion protein.
    J Virol. 2024;98:e0153624.
    >> Share

  239. NEAL HE, Barrett CT, Edmonds K, Moncman CL, et al
    Examination of respiratory syncytial virus fusion protein proteolytic processing and roles of the P27 domain.
    J Virol. 2024;98:e0163924.
    >> Share

  240. TAKAHASHI T, Amarbayasgalan S, Ueno S, Sugiura Y, et al
    Lethal model for respiratory syncytial virus infection using C57BL/6 mice.
    J Virol. 2024;98:e0177224.
    >> Share

  241. LV H, Teo QW, Lee C-CD, Liang W, et al
    Differential antigenic imprinting effects between influenza H1N1 hemagglutinin and neuraminidase in a mouse model.
    J Virol. 2024 Dec 5:e0169524. doi: 10.1128/jvi.01695.
    >> Share

  242. YANG K, Nizami S, Hu S, Zou L, et al
    Genetic diversity of highly pathogenic avian influenza H5N6 and H5N8 viruses in poultry markets in Guangdong, China, 2020-2022.
    J Virol. 2024 Dec 4:e0114524. doi: 10.1128/jvi.01145.
    >> Share

    November 2024
  243. KAKIZAKI M, Hashimoto R, Nagata N, Yamamoto T, et al
    The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids.
    J Virol. 2024 Nov 27:e0185324. doi: 10.1128/jvi.01853.
    >> Share

  244. SHETTY N, Shephard MJ, Rockey NC, Macenczak H, et al
    Influenza virus infection and aerosol shedding kinetics in a controlled human infection model.
    J Virol. 2024 Nov 26:e0161224. doi: 10.1128/jvi.01612.
    >> Share

  245. FUJIMOTO Y, Ozaki K, Ono E
    Chicken ANP32A-independent replication of highly pathogenic avian influenza viruses potentially leads to mammalian adaptation-related amino acid substitutions in viral PB2 and PA proteins.
    J Virol. 2024 Nov 21:e0184024. doi: 10.1128/jvi.01840.
    >> Share

  246. BOLLAND W, Marechal I, Petiot C, Porrot F, et al
    SARS-CoV-2 entry and fusion are independent of ACE2 localization to lipid rafts.
    J Virol. 2024 Nov 21:e0182324. doi: 10.1128/jvi.01823.
    >> Share

  247. PATINO-GALINDO J, Garcia-Sastre A, Kuhn JH, Rabadan R, et al
    Recombination across distant coronavirid species and genera is a rare event with distinct genomic features.
    J Virol. 2024 Nov 19:e0110024. doi: 10.1128/jvi.01100.
    >> Share

  248. LI C, Culhane MR, Schroeder DC, Cheeran MC-J, et al
    Quantifying the impact of vaccination on transmission and diversity of influenza A variants in pigs.
    J Virol. 2024 Nov 12:e0124524. doi: 10.1128/jvi.01245.
    >> Share

  249. POWELL JD, Thomas MN, Anderson TK, Zeller MA, et al
    2018-2019 human seasonal H3N2 influenza A virus spillovers into swine with demonstrated virus transmission in pigs were not sustained in the pig population.
    J Virol. 2024 Nov 11:e0008724. doi: 10.1128/jvi.00087.
    >> Share

  250. CHEN D, Zhang W, Xiao B, Xu B, et al
    Effect of wild-type vaccine doses on BA.5 hybrid immunity, disease severity, and XBB reinfection risk.
    J Virol. 2024 Nov 5:e0128524. doi: 10.1128/jvi.01285.
    >> Share

  251. SUN X, Belser JA, Pulit-Penaloza JA, Brock N, et al
    Dissecting the role of the HA1-226 leucine residue in the fitness and airborne transmission of an A(H9N2) avian influenza virus.
    J Virol. 2024 Nov 4:e0092824. doi: 10.1128/jvi.00928.
    >> Share

  252. STEIN SC, Hansen G, Ssebyatika G, Stroh LJ, et al
    A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation.
    J Virol. 2024 Nov 4:e0122324. doi: 10.1128/jvi.01223.
    >> Share

  253. PARRY RH, Lytras S, Petrone ME, Wille M, et al
    No evidence that mutations in SARS-CoV-2 variants of concern derive from homologous fragments in gut microbiota.
    J Virol. 2024 Nov 4:e0146824. doi: 10.1128/jvi.01468.
    >> Share

    October 2024
  254. ZHANG C, Jiang Q, Liu Z, Li N, et al
    SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptor.
    J Virol. 2024 Oct 24:e0075424. doi: 10.1128/jvi.00754.
    >> Share

  255. SHAHRIARI S, Ghildyal R
    The actin-binding protein palladin associates with the respiratory syncytial virus matrix protein.
    J Virol. 2024;98:e0143524.
    >> Share

  256. FAURE-DUPUY S, Depierre M, Fremont-Debaene Z, Herit F, et al
    Human rhinovirus 16 induces an ICAM-1-PKR-ATF2 axis to modulate macrophage functions.
    J Virol. 2024;98:e0149924.
    >> Share

  257. HAN Y, Zhou H, Liu C, Wang W, et al
    SARS-CoV-2 N protein coordinates viral particle assembly through multiple domains.
    J Virol. 2024 Oct 16:e0103624. doi: 10.1128/jvi.01036.
    >> Share

  258. TRIMARCO JD, Spurrier MA, Skavicus S, Luo Z, et al
    Fluorescent and bioluminescent bovine H5N1 influenza viruses for evaluation of antiviral interventions.
    J Virol. 2024 Oct 10:e0138524. doi: 10.1128/jvi.01385.
    >> Share

  259. LI A, Zhao K, Duan Y, Zhang B, et al
    SARS-CoV-2 nsp13 suppresses hepatitis B virus replication by targeting cccDNA transcription.
    J Virol. 2024 Oct 7:e0104224. doi: 10.1128/jvi.01042.
    >> Share

  260. WANG W, Bhushan G, Paz S, Stauft CB, et al
    Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1.
    J Virol. 2024 Oct 4:e0094824. doi: 10.1128/jvi.00948.
    >> Share

  261. DO THT, Wille M, Wheatley AK, Koutsakos M, et al
    Triton X-100-treated virus-based ELLA demonstrates discordant antigenic evolution of influenza B virus hemagglutinin and neuraminidase.
    J Virol. 2024 Oct 3:e0118624. doi: 10.1128/jvi.01186.
    >> Share

    September 2024
  262. HAMELE CE, Luo Z, Leonard RA, Spurrier MA, et al
    Headless hemagglutinin-containing influenza viral particles direct immune responses toward more conserved epitopes.
    J Virol. 2024 Sep 26:e0116624. doi: 10.1128/jvi.01166.
    >> Share

  263. LOES AN, Tarabi RAL, Huddleston J, Touyon L, et al
    High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains.
    J Virol. 2024 Sep 24:e0068924. doi: 10.1128/jvi.00689.
    >> Share

  264. DAVID SC, Schaub A, Terrettaz C, Motos G, et al
    Correction for David et al., "Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria".
    J Virol. 2024 Sep 19:e0122224. doi: 10.1128/jvi.01222.
    >> Share

  265. WANG Z, Qiu M, Ji Y, Chai K, et al
    Palmitoylation of SARS-CoV-2 Envelope protein is central to virus particle formation.
    J Virol. 2024 Sep 17:e0107224. doi: 10.1128/jvi.01072.
    >> Share

  266. BROOKS K, Nelson CE, Aguilar C, Hoang TN, et al
    SARS-CoV-2 infection perturbs the gastrointestinal tract and induces modest microbial translocation across the intestinal barrier.
    J Virol. 2024 Sep 12:e0128824. doi: 10.1128/jvi.01288.
    >> Share

  267. HAN M, Lu Q, Wang D, Zhou K, et al
    Oral co-administration of Lactiplantibacillus plantarum 16 and Lacticaseibacillus rhamnosus P118 improves host defense against influenza A virus infection.
    J Virol. 2024 Sep 11:e0095024. doi: 10.1128/jvi.00950.
    >> Share

  268. SOUDANI N, Bricker TL, Darling T, Seehra K, et al
    Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamsters.
    J Virol. 2024 Sep 4:e0052824. doi: 10.1128/jvi.00528.
    >> Share

  269. GUAN M, DeLiberto TJ, Feng A, Zhang J, et al
    Neu5Gc binding loss of subtype H7 influenza A virus facilitates adaptation to gallinaceous poultry following transmission from waterbirds.
    J Virol. 2024 Sep 3:e0011924. doi: 10.1128/jvi.00119.
    >> Share

    August 2024
  270. YANG Y, Xu C, Zhang N, Wan Y, et al
    Two amino acid residues in the N-terminal region of the polymerase acidic protein determine the virulence of Eurasian avian-like H1N1 swine influenza viruses in mice.
    J Virol. 2024 Aug 30:e0129324. doi: 10.1128/jvi.01293.
    >> Share

  271. BARRETO-DURAN E, Synowiec A, Szczepanski A, Galuszka-Bulaga A, et al
    Development of an intestinal mucosa ex vivo co-culture model to study viral infections.
    J Virol. 2024 Aug 30:e0098724. doi: 10.1128/jvi.00987.
    >> Share

  272. HU Y, Jin Y, Han D, Zhang G, et al
    Correction for Hu et al., "Mast Cell-Induced Lung Injury in Mice Infected with H5N1 Influenza Virus".
    J Virol. 2024 Aug 29:e0110624. doi: 10.1128/jvi.01106.
    >> Share

  273. ALFADHLI A, Bates TA, Barklis RL, Romanaggi C, et al
    A nanobody interaction with SARS-COV-2 Spike allows the versatile targeting of lentivirus vectors.
    J Virol. 2024 Aug 29:e0079524. doi: 10.1128/jvi.00795.
    >> Share

  274. DMYTRENKO O, Das S, Kovacs A, Cicka M, et al
    Infiltrating monocytes drive cardiac dysfunction in a cardiomyocyte-restricted mouse model of SARS-CoV-2 infection.
    J Virol. 2024 Aug 29:e0117924. doi: 10.1128/jvi.01179.
    >> Share

  275. LIEBER CM, Kang H-J, Sobolik EB, Sticher ZM, et al
    Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection.
    J Virol. 2024 Aug 29:e0090524. doi: 10.1128/jvi.00905.
    >> Share

  276. GOODWIN E, Gibbs JS, Yewdell JW, Eisenlohr LC, et al
    Influenza virus antibodies inhibit antigen-specific de novo B cell responses in mice.
    J Virol. 2024 Aug 28:e0076624. doi: 10.1128/jvi.00766.
    >> Share

  277. HARTWIG SM, Odle A, Wong L-YR, Meyerholz DK, et al
    Respiratory syncytial virus infection provides protection against severe acute respiratory syndrome coronavirus challenge.
    J Virol. 2024 Aug 28:e0066924. doi: 10.1128/jvi.00669.
    >> Share

  278. YING B, Liang C-Y, Desai P, Scheaffer SM, et al
    Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain.
    J Virol. 2024 Aug 28:e0057424. doi: 10.1128/jvi.00574.
    >> Share

  279. ZHU J, Liu G, Sayyad Z, Goins CM, et al
    ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis.
    J Virol. 2024 Aug 28:e0086924. doi: 10.1128/jvi.00869.
    >> Share

  280. TERASAKI K, Makino S
    Requirement of the N-terminal region of nonstructural protein 1 in cis for SARS-CoV-2 defective RNA replication.
    J Virol. 2024 Aug 28:e0090024. doi: 10.1128/jvi.00900.
    >> Share

  281. WANG G, Verma AK, Guan X, Bu F, et al
    Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge.
    J Virol. 2024 Aug 27:e0037624. doi: 10.1128/jvi.00376.
    >> Share

  282. UNO N, Ebensen T, Guzman CA, Ross TM, et al
    Intranasal administration of octavalent next-generation influenza vaccine elicits protective immune responses against seasonal and pre-pandemic viruses.
    J Virol. 2024 Aug 22:e0035424. doi: 10.1128/jvi.00354.
    >> Share

  283. WANG L, Shi L, Liu H, Zhang J, et al
    Incompatible packaging signals and impaired protein functions hinder reassortment of bat H17N10 or H18N11 segment 7 with human H1N1 influenza A viruses.
    J Virol. 2024 Aug 20:e0086424. doi: 10.1128/jvi.00864.
    >> Share

  284. GAO Y, Raghavan A, Espinosa Garcia SA, Deng B, et al
    In vitro higher-order oligomeric assembly of the respiratory syncytial virus M2-1 protein with longer RNAs.
    J Virol. 2024;98:e0104624.
    >> Share

  285. MUSA AO, Faber SR, Forrest K, Smith KP, et al
    Identification of distinct genotypes in circulating RSV A strains based on variants in the virus replication-associated genes.
    J Virol. 2024;98:e0099024.
    >> Share

  286. BARBOSA BOMFIM CC, Genin H, Cottoignies-Callamarte A, Gallois-Montbrun S, et al
    CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its pulmonary levels correlate with viral clearance in critical COVID-19 patients.
    J Virol. 2024 Aug 20:e0012824. doi: 10.1128/jvi.00128.
    >> Share

  287. RHAMADIANTI AF, Abe T, Tanaka T, Ono C, et al
    SARS-CoV-2 papain-like protease inhibits ISGylation of the viral nucleocapsid protein to evade host anti-viral immunity.
    J Virol. 2024 Aug 9:e0085524. doi: 10.1128/jvi.00855.
    >> Share

  288. ALWINE J, Goodrum F, Banfield B, Bloom D, et al
    The harms of promoting the lab leak hypothesis for SARS-CoV-2 origins without evidence.
    J Virol. 2024 Aug 1:e0124024. doi: 10.1128/jvi.01240.
    >> Share

    July 2024
  289. AMOAH S, Cao W, Sayedahmed EE, Wang Y, et al
    The frequency and function of nucleoprotein-specific CD8(+) T cells are critical for heterosubtypic immunity against influenza virus infection.
    J Virol. 2024 Jul 31:e0071124. doi: 10.1128/jvi.00711.
    >> Share

  290. WIGGINS KB, Winston SM, Reeves IL, Gaevert J, et al
    rAAV expressing a COBRA-designed influenza hemagglutinin generates a protective and durable adaptive immune response with a single dose.
    J Virol. 2024 Jul 30:e0078124. doi: 10.1128/jvi.00781.
    >> Share

  291. SPACKMAN E, Jones DR, McCoig AM, Colonius TJ, et al
    Characterization of highly pathogenic avian influenza virus in retail dairy products in the US.
    J Virol. 2024 Jul 3:e0088124. doi: 10.1128/jvi.00881.
    >> Share

  292. RICHARDSON SI, Mzindle N, Motlou T, Manamela NP, et al
    SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcgammaRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.
    J Virol. 2024 Jul 2:e0067824. doi: 10.1128/jvi.00678.
    >> Share

    June 2024
  293. YU X, Tian J, Wang Y, Su N, et al
    The pseudogene GBP1P1 suppresses influenza A virus replication by acting as a protein decoy for DHX9.
    J Virol. 2024 Jun 28:e0073824. doi: 10.1128/jvi.00738.
    >> Share

  294. PECHOUS RD, Malaviarachchi PA, Banerjee SK, Byrum SD, et al
    An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy.
    J Virol. 2024 Jun 28:e0079424. doi: 10.1128/jvi.00794.
    >> Share

  295. CHEN Z, Cui Q, Ran Y, Achi JG, et al
    A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation.
    J Virol. 2024 Jun 20:e0050424. doi: 10.1128/jvi.00504.
    >> Share

  296. STAHL-HENNIG C, Peter AS, Cordsmeier A, Stolte-Leeb N, et al
    Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model.
    J Virol. 2024 Jun 20:e0062824. doi: 10.1128/jvi.00628.
    >> Share

  297. PAN R, Li P, Meyerholz DK, Perlman S, et al
    Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice.
    J Virol. 2024 Jun 18:e0058424. doi: 10.1128/jvi.00584.
    >> Share

  298. ZHU J, Wang Z, Li Y, Zhang Z, et al
    Trimerized S expressed by modified vaccinia virus Ankara (MVA) confers superior protection against lethal SARS-CoV-2 challenge in mice.
    J Virol. 2024 Jun 14:e0052124. doi: 10.1128/jvi.00521.
    >> Share

  299. DAVID SC, Schaub A, Terrettaz C, Motos G, et al
    Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria.
    J Virol. 2024 Jun 13:e0040924. doi: 10.1128/jvi.00409.
    >> Share

    May 2024
  300. HUANG Y, Owino SO, Crevar CJ, Carter DM, et al
    Correction for Huang et al., "N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies".
    J Virol. 2024 May 31:e0112823. doi: 10.1128/jvi.01128.
    >> Share

  301. CARTER DM, Darby CA, Lefoley BC, Crevar CJ, et al
    Correction for Carter et al., "Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses".
    J Virol. 2024 May 31:e0181323. doi: 10.1128/jvi.01813.
    >> Share

  302. CARTER DM, Darby CA, Johnson SK, Carlock MA, et al
    Retraction for Carter et al., "Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses".
    J Virol. 2024 May 31:e0183223. doi: 10.1128/jvi.01832.
    >> Share

  303. RAHMAN SM, Buchholz DW, Imbiakha B, Jager MC, et al
    Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2-infected older mice with neurological signs.
    J Virol. 2024 May 30:e0006624. doi: 10.1128/jvi.00066.
    >> Share

  304. MARIZZI C, Ajayi PK, McMahon R, Meade PS, et al
    A community science approach to public health and public trust in science.
    J Virol. 2024 May 29:e0082524. doi: 10.1128/jvi.00825.
    >> Share

  305. KNOLL M, Honce R, Meliopoulos V, Segredo-Otero EA, et al
    Host obesity impacts genetic variation in influenza A viral populations.
    J Virol. 2024 May 24:e0177823. doi: 10.1128/jvi.01778.
    >> Share

  306. SCHWAB LSU, Do THT, Pilapitiya D, Koutsakos M, et al
    Dissemination of influenza B virus to the lower respiratory tract of mice is restricted by the interferon response.
    J Virol. 2024 May 23:e0160423. doi: 10.1128/jvi.01604.
    >> Share

  307. MA MT, Jiang Q, Chen C-H, Badeti S, et al
    S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.
    J Virol. 2024 May 20:e0003824. doi: 10.1128/jvi.00038.
    >> Share

  308. MEADE PS, Bandawane P, Bushfield K, Hoxie I, et al
    Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York City.
    J Virol. 2024 May 15:e0062624. doi: 10.1128/jvi.00626.
    >> Share

  309. CESAR RAMOS DE JESUS H, Solis N, Machado Y, Pablos I, et al
    Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL(pro) main protease (Mpro) from proteomic identification of P6-P6' active site specificity.
    J Virol. 2024 May 14:e0004924. doi: 10.1128/jvi.00049.
    >> Share

  310. YU M, Li J, Gao W, Li Z, et al
    Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
    J Virol. 2024 May 6:e0162423. doi: 10.1128/jvi.01624.
    >> Share

    April 2024
  311. VIOX EG, Bosinger SE, Douek DC, Schreiber G, et al
    Harnessing the power of IFN for therapeutic approaches to COVID-19.
    J Virol. 2024 Apr 23:e0120423. doi: 10.1128/jvi.01204.
    >> Share

  312. MAO D, Liu S, Phan AT, Renner S, et al
    The TRAF3-DYRK1A-RAD54L2 complex maintains ACE2 expression to promote SARS-CoV-2 infection.
    J Virol. 2024 Apr 23:e0034724. doi: 10.1128/jvi.00347.
    >> Share

  313. HAN Y, Yuan Z, Yi Z
    Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.
    J Virol. 2024 Apr 19:e0034924. doi: 10.1128/jvi.00349.
    >> Share

  314. BOUGON J, Kadijk E, Gallot-Lavallee L, Curtis BA, et al
    Influenza A virus NS1 effector domain is required for PA-X-mediated host shutoff in infected cells.
    J Virol. 2024 Apr 17:e0190123. doi: 10.1128/jvi.01901.
    >> Share

  315. PEREZ DR
    A devastating blow: personal reflections on Argentina's scientific decline.
    J Virol. 2024 Apr 16:e0054924. doi: 10.1128/jvi.00549.
    >> Share

  316. ISHIMARU H, Nishimura M, Shigematsu H, Marini MI, et al
    Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.
    J Virol. 2024 Apr 16:e0041624. doi: 10.1128/jvi.00416.
    >> Share

  317. TAKADA K, Orba Y, Kida Y, Wu J, et al
    Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.
    J Virol. 2024 Apr 16:e0178423. doi: 10.1128/jvi.01784.
    >> Share

  318. BU H, Zhang S, Li P, Liu Z, et al
    Secreted phospholipase PLA2G2E contributes to regulation of T cell immune response against influenza virus infection.
    J Virol. 2024 Apr 9:e0019824. doi: 10.1128/jvi.00198.
    >> Share

  319. BOON ACM, Bricker TL, Fritch EJ, Leist SR, et al
    Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
    J Virol. 2024 Apr 9:e0190323. doi: 10.1128/jvi.01903.
    >> Share

  320. YANG R, Han P, Han P, Li D, et al
    Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
    J Virol. 2024 Apr 9:e0045124. doi: 10.1128/jvi.00451.
    >> Share

  321. XIAO X, Fu Y, You W, Huang C, et al
    Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
    J Virol. 2024 Apr 4:e0157323. doi: 10.1128/jvi.01573.
    >> Share

  322. MAES A, Botzki A, Mathys J, Impens F, et al
    Systematic review and meta-analysis of genome-wide pooled CRISPR screens to identify host factors involved in influenza A virus infection.
    J Virol. 2024 Apr 3:e0185723. doi: 10.1128/jvi.01857.
    >> Share

  323. SILVA F, Boal-Carvalho I, Williams N, Chabert M, et al
    Identification of a short sequence motif in the influenza A virus pathogenicity factor PB1-F2 required for inhibition of human NLRP3.
    J Virol. 2024 Apr 3:e0041124. doi: 10.1128/jvi.00411.
    >> Share

  324. KEOWN J, Baazaoui A, Sebesta M, Stefl R, et al
    Structural and functional characterization of the interaction between the influenza A virus RNA polymerase and the CTD of host RNA polymerase II.
    J Virol. 2024 Apr 2:e0013824. doi: 10.1128/jvi.00138.
    >> Share

  325. BRUNET J, Choucha Z, Gransagne M, Tabbal H, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
    J Virol. 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693.
    >> Share

  326. NAMBULLI S, Escriou N, Rennick LJ, Demers MJ, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
    J Virol. 2024 Apr 2:e0176223. doi: 10.1128/jvi.01762.
    >> Share

    March 2024
  327. MAI F, Bergmann W, Reisinger EC, Muller-Hilke B, et al
    The varying extent of humoral and cellular immune responses to either vector- or RNA-based SARS-CoV-2 vaccines persists for at least 18 months and is independent of infection.
    J Virol. 2024 Mar 19:e0191223. doi: 10.1128/jvi.01912.
    >> Share

  328. BABOT M, Boulard Y, Agouda S, Pieri L, et al
    Oligomeric assembly of the C-terminal and transmembrane region of SARS-CoV-2 nsp3.
    J Virol. 2024 Mar 14:e0157523. doi: 10.1128/jvi.01575.
    >> Share

  329. SPRUIT CM, Palme DI, Li T, Rios Carrasco M, et al
    Complex N-glycans are important for interspecies transmission of H7 influenza A viruses.
    J Virol. 2024 Mar 12:e0194123. doi: 10.1128/jvi.01941.
    >> Share

  330. HEINDL MR, Rupp A-L, Schwerdtner M, Bestle D, et al
    ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.
    J Virol. 2024 Mar 12:e0010224. doi: 10.1128/jvi.00102.
    >> Share

  331. WEN F, Yan Z, Chen G, Chen Y, et al
    Recent H9N2 avian influenza virus lost hemagglutination activity due to a K141N substitution in hemagglutinin.
    J Virol. 2024 Mar 11:e0024824. doi: 10.1128/jvi.00248.
    >> Share

  332. ZHENG T, Shen B, Bai Y, Li E, et al
    The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association.
    J Virol. 2024 Mar 6:e0156523. doi: 10.1128/jvi.01565.
    >> Share

    February 2024
  333. ZHANG M, Liu M, Chen H, Qiu T, et al
    PB2 residue 473 contributes to the mammalian virulence of H7N9 avian influenza virus by modulating viral polymerase activity via ANP32A.
    J Virol. 2024 Feb 29:e0194423. doi: 10.1128/jvi.01944.
    >> Share

  334. MARTINS M, Nooruzzaman M, Cunningham JL, Ye C, et al
    The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection.
    J Virol. 2024 Feb 29:e0190223. doi: 10.1128/jvi.01902.
    >> Share

  335. HAN J, Chang W, Fang J, Hou X, et al
    The H9N2 avian influenza virus increases APEC adhesion to oviduct epithelia by viral NS1 protein-mediated activation of the TGF-beta pathway.
    J Virol. 2024 Feb 28:e0151223. doi: 10.1128/jvi.01512.
    >> Share

  336. UPRETY T, Yu J, Nogales A, Naveed A, et al
    Influenza D virus utilizes both 9-O-acetylated N-acetylneuraminic and 9-O-acetylated N-glycolylneuraminic acids as functional entry receptors.
    J Virol. 2024 Feb 20:e0004224. doi: 10.1128/jvi.00042.
    >> Share

  337. NIE L, Huang Y, Cheng Z, Luo H, et al
    An intranasal influenza virus vector vaccine protects against Helicobacter pylori in mice.
    J Virol. 2024 Feb 15:e0192323. doi: 10.1128/jvi.01923.
    >> Share

  338. ZENG J, Du F, Xiao L, Sun H, et al
    Spatiotemporal genotype replacement of H5N8 avian influenza viruses contributed to H5N1 emergence in 2021/2022 panzootic.
    J Virol. 2024 Feb 15:e0140123. doi: 10.1128/jvi.01401.
    >> Share

  339. THOMAS MN, Zanella GC, Cowan B, Caceres CJ, et al
    Nucleoprotein reassortment enhanced transmissibility of H3 1990.4.a clade influenza A virus in swine.
    J Virol. 2024 Feb 14:e0170323. doi: 10.1128/jvi.01703.
    >> Share

  340. KATAYAMA M, Murakami S, Ishida H, Matsugo H, et al
    Antigenic commonality and divergence of hemagglutinin-esterase-fusion protein among influenza D virus lineages revealed using epitope mapping.
    J Virol. 2024 Feb 12:e0190823. doi: 10.1128/jvi.01908.
    >> Share

  341. VANSLAMBROUCK JM, Neil JA, Rudraraju R, Mah S, et al
    Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection.
    J Virol. 2024 Feb 9:e0180223. doi: 10.1128/jvi.01802.
    >> Share

  342. SHINGAI M, Iida S, Kawai N, Kawahara M, et al
    Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon influenza virus infection by subtraction of the background antibody repertoire.
    J Virol. 2024 Feb 7:e0199523. doi: 10.1128/jvi.01995.
    >> Share

  343. YANG Q, Barbachano-Guerrero A, Fairchild LM, Rowland TJ, et al
    Macrophages derived from human induced pluripotent stem cells (iPSCs) serve as a high-fidelity cellular model for investigating HIV-1, dengue, and influenza viruses.
    J Virol. 2024 Feb 7:e0156323. doi: 10.1128/jvi.01563.
    >> Share

  344. LI H, Sun H, Tao M, Han Q, et al
    Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin protein confers broad protection against H5Ny influenza viruses.
    J Virol. 2024 Feb 2:e0112923. doi: 10.1128/jvi.01129.
    >> Share

  345. NIU S, Zhao Z, Liu Z, Rong X, et al
    Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.
    J Virol. 2024 Feb 2:e0115723. doi: 10.1128/jvi.01157.
    >> Share

  346. BRICKER TL, Joshi A, Soudani N, Scheaffer SM, et al
    Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.
    J Virol. 2024 Feb 2:e0120623. doi: 10.1128/jvi.01206.
    >> Share

  347. HSIEH M-S, Hsu C-W, Liao H-C, Lin C-L, et al
    SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.
    J Virol. 2024 Feb 1:e0154623. doi: 10.1128/jvi.01546.
    >> Share

    January 2024
  348. ROWE T, Davis W, Wentworth DE, Ross T, et al
    Differential interferon responses to influenza A and B viruses in primary ferret respiratory epithelial cells.
    J Virol. 2024 Jan 31:e0149423. doi: 10.1128/jvi.01494.
    >> Share

  349. SHEN S, Guo H, Li Y, Zhang L, et al
    SARS-CoV-2 and oncolytic EV-D68-encoded proteases differentially regulate pyroptosis.
    J Virol. 2024 Jan 30:e0190923. doi: 10.1128/jvi.01909.
    >> Share

  350. KIERAN TJ, Sun X, Maines TR, Beauchemin CAA, et al
    Exploring associations between viral titer measurements and disease outcomes in ferrets inoculated with 125 contemporary influenza A viruses.
    J Virol. 2024 Jan 19:e0166123. doi: 10.1128/jvi.01661.
    >> Share

  351. DULIN H, Barre RS, Xu D, Neal A, et al
    Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.
    J Virol. 2024 Jan 11:e0157123. doi: 10.1128/jvi.01571.
    >> Share

  352. HE Y, Guo Z, Subiaur S, Benegal A, et al
    Antibody inhibition of influenza A virus assembly and release.
    J Virol. 2024 Jan 5:e0139823. doi: 10.1128/jvi.01398.
    >> Share

  353. DEY S, Mondal A
    Unveiling the role of host kinases at different steps of influenza A virus life cycle.
    J Virol. 2024 Jan 4:e0119223. doi: 10.1128/jvi.01192.
    >> Share

  354. FARJO M, Koelle K, Martin MA, Gibson LL, et al
    Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection.
    J Virol. 2024 Jan 4:e0161823. doi: 10.1128/jvi.01618.
    >> Share

  355. LI K, Verma A, Li P, Ortiz ME, et al
    Adaptation of SARS-CoV-2 to ACE2(H353K) mice reveals new spike residues that drive mouse infection.
    J Virol. 2024 Jan 3:e0151023. doi: 10.1128/jvi.01510.
    >> Share

  356. RASMUSSEN AL, Gronvall GK, Lowen AC, Goodrum F, et al
    Virology-the path forward.
    J Virol. 2024 Jan 3:e0179123. doi: 10.1128/jvi.01791.
    >> Share

    December 2023
  357. BOLLAND W, Michel V, Planas D, Hubert M, et al
    High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.
    J Virol. 2023 Dec 13:e0135123. doi: 10.1128/jvi.01351.
    >> Share

  358. JERONIMO PMC, Aksenen CF, Duarte IO, Lins RD, et al
    Evolutionary deletions within the SARS-CoV-2 genome as signature trends for virus fitness and adaptation.
    J Virol. 2023 Dec 13:e0140423. doi: 10.1128/jvi.01404.
    >> Share

  359. ZHANG L, Shao Y, Wang Y, Yang Q, et al
    Twenty natural amino acid substitution screening at the last residue 121 of influenza A virus NS2 protein reveals the critical role of NS2 in promoting virus genome replication by coordinating with viral polymerase.
    J Virol. 2023 Dec 6:e0116623. doi: 10.1128/jvi.01166.
    >> Share

  360. PHAM TX, Huynh TTX, Choi J, Lee J-B, et al
    SARS-CoV-2 exploits cellular RAD51 to promote viral propagation: implication of RAD51 inhibitor as a potential drug candidate against COVID-19.
    J Virol. 2023 Dec 5:e0173723. doi: 10.1128/jvi.01737.
    >> Share

  361. ZAYOU L, Prakash S, Dhanushkodi NR, Quadiri A, et al
    A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4(+) and CD8(+) T cells and enhanced protection against COVID-19-like symptoms and death caused by SARS-CoV-2 infection.
    J Virol. 2023 Dec 1:e0109623. doi: 10.1128/jvi.01096.
    >> Share

    November 2023
  362. LI K, Huntwork RHC, Horn GQ, Abraha M, et al
    Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.
    J Virol. 2023 Nov 29:e0107023. doi: 10.1128/jvi.01070.
    >> Share

  363. DOMINGO E, Martinez-Gonzalez B, Garcia-Crespo C, Somovilla P, et al
    Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies.
    J Virol. 2023 Nov 21:e0151123. doi: 10.1128/jvi.01511.
    >> Share

  364. BRAGAZZI CUNHA J, Leix K, Sherman EJ, Mirabelli C, et al
    Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection.
    J Virol. 2023 Nov 17:e0127623. doi: 10.1128/jvi.01276.
    >> Share

  365. ALRUWAILI M, Armstrong S, Prince T, Erdmann M, et al
    SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption.
    J Virol. 2023 Nov 6:e0042423. doi: 10.1128/jvi.00424.
    >> Share

  366. SUN W, Xu J, Wang Z, Li D, et al
    Clade 2.3.4.4 H5 chimeric cold-adapted attenuated influenza vaccines induced cross-reactive protection in mice and ferrets.
    J Virol. 2023 Nov 2:e0110123. doi: 10.1128/jvi.01101.
    >> Share

  367. RIJNINK WF, Stadlbauer D, Puente-Massaguer E, Okba NMA, et al
    Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses.
    J Virol. 2023 Nov 2:e0164622. doi: 10.1128/jvi.01646.
    >> Share

    October 2023
  368. PAHMEIER F, Lavacca T-M, Goellner S, Neufeldt CJ, et al
    Identification of host dependency factors involved in SARS-CoV-2 replication organelle formation through proteomics and ultrastructural analysis.
    J Virol. 2023 Oct 31:e0087823. doi: 10.1128/jvi.00878.
    >> Share

  369. CAO J, Shi M, Zhu L, Li X, et al
    The matrix protein of respiratory syncytial virus suppresses interferon signaling via RACK1 association.
    J Virol. 2023;97:e0074723.
    >> Share

  370. BARTSCH YC, Cizmeci D, Yuan D, Mehta N, et al
    Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine.
    J Virol. 2023 Oct 30:e0077123. doi: 10.1128/jvi.00771.
    >> Share

  371. LI Y, Arcos S, Sabsay KR, Te Velthuis AJW, et al
    Deep mutational scanning reveals the functional constraints and evolutionary potential of the influenza A virus PB1 protein.
    J Virol. 2023 Oct 26:e0132923. doi: 10.1128/jvi.01329.
    >> Share

  372. YAN Z, Li Y, Huang S, Wen F, et al
    Global distribution, receptor binding, and cross-species transmission of H6 influenza viruses: risks and implications for humans.
    J Virol. 2023 Oct 25:e0137023. doi: 10.1128/jvi.01370.
    >> Share

  373. UNDI RB, Ahsan N, Larabee JL, Darlene-Reuter N, et al
    Blocking of doublecortin-like kinase 1-regulated SARS-CoV-2 replication cycle restores cell signaling network.
    J Virol. 2023 Oct 20:e0119423. doi: 10.1128/jvi.01194.
    >> Share

  374. KUMAR S, Delipan R, Chakraborty D, Kanjo K, et al
    Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity.
    J Virol. 2023 Oct 20:e0092223. doi: 10.1128/jvi.00922.
    >> Share

  375. YE G, Pan R, Bu F, Zheng J, et al
    Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19.
    J Virol. 2023 Oct 19:e0144823. doi: 10.1128/jvi.01448.
    >> Share

  376. SUN H, Wang Y, Chen X, Jiang Y, et al
    Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant.
    J Virol. 2023 Oct 19:e0113723. doi: 10.1128/jvi.01137.
    >> Share

  377. JOHNSON RM, Ardanuy J, Hammond H, Logue J, et al
    Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2.
    J Virol. 2023 Oct 17:e0133623. doi: 10.1128/jvi.01336.
    >> Share

  378. LIANG CY, Huang I, Han J, Sownthirarajan B, et al
    Avian influenza A viruses exhibit plasticity in sialylglycoconjugate receptor usage in human lung cells.
    J Virol. 2023 Oct 16:e0090623. doi: 10.1128/jvi.00906.
    >> Share

  379. WU Y, Shi J, He X, Lu J, et al
    Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants.
    J Virol. 2023 Oct 16:e0127923. doi: 10.1128/jvi.01279.
    >> Share

  380. MISPLON JA, Lo CY, Crabbs TA, Price GE, et al
    Adenoviral-vectored universal influenza vaccines administered intranasally reduce lung inflammatory responses upon viral challenge 15 months post-vaccination.
    J Virol. 2023 Oct 13:e0067423. doi: 10.1128/jvi.00674.
    >> Share

  381. MIURA K, Suzuki Y, Ishida K, Arakawa M, et al
    Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells.
    J Virol. 2023 Oct 13:e0042623. doi: 10.1128/jvi.00426.
    >> Share

  382. MAHE D, Bourgeau S, da Silva J, Schlederer J, et al
    SARS-CoV-2 replicates in the human testis with slow kinetics and has no major deleterious effects ex vivo.
    J Virol. 2023 Oct 13:e0110423. doi: 10.1128/jvi.01104.
    >> Share

  383. RIBO-MOLINA P, Weiss HJ, Susma B, van Nieuwkoop S, et al
    4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1.
    J Virol. 2023 Oct 12:e0132523. doi: 10.1128/jvi.01325.
    >> Share

  384. ISELI AN, Pohl MO, Glas I, Gaggioli E, et al
    The neuraminidase activity of influenza A virus determines the strain-specific sensitivity to neutralization by respiratory mucus.
    J Virol. 2023 Oct 11:e0127123. doi: 10.1128/jvi.01271.
    >> Share

  385. GIRARD J, Jakob C, Toews LK, Fuchs J, et al
    Disruption of influenza virus packaging signals results in various misassembled genome complexes.
    J Virol. 2023 Oct 9:e0107623. doi: 10.1128/jvi.01076.
    >> Share

  386. CARNACCINI S, Caceres CJ, Gay LC, Ferreri LM, et al
    Antigenic mapping of the hemagglutinin of the H9 subtype influenza A viruses using sera from Japanese quail (Coturnix c. japonica).
    J Virol. 2023 Oct 6:e0074323. doi: 10.1128/jvi.00743.
    >> Share

  387. MCMAHON M, Tan J, O'Dell G, Kirkpatrick Roubidoux E, et al
    Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner.
    J Virol. 2023 Oct 6:e0105723. doi: 10.1128/jvi.01057.
    >> Share

  388. KIMURA I, Yamasoba D, Nasser H, Ito H, et al
    Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
    J Virol. 2023 Oct 5:e0101123. doi: 10.1128/jvi.01011.
    >> Share

  389. MENG X, Veit M
    Palmitoylation of the hemagglutinin of influenza B virus by ER-localized DHHC enzymes 1, 2, 4, and 6 is required for efficient virus replication.
    J Virol. 2023 Oct 4:e0124523. doi: 10.1128/jvi.01245.
    >> Share

    September 2023
  390. ZHAO Y, Sui L, Wu P, Li L, et al
    EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8.
    J Virol. 2023 Sep 29:e0102823. doi: 10.1128/jvi.01028.
    >> Share

  391. LI J, Gui Q, Liang FX, Sall J, et al
    The REEP5/TRAM1 complex binds SARS-CoV-2 NSP3 and promotes virus replication.
    J Virol. 2023 Sep 28:e0050723. doi: 10.1128/jvi.00507.
    >> Share

  392. NENNA R, Stern DA, Carr TF, Spangenberg A, et al
    Prenatal exposure to RSV season influences first-year risk of RSV lower respiratory illness and RSV-specific immune responses assessed at birth.
    J Virol. 2023;97:e0076723.
    >> Share

  393. WALLACE LE, de Vries E, van Kuppeveld FJM, de Haan CAM, et al
    Neuraminidase-dependent entry of influenza A virus is determined by hemagglutinin receptor-binding specificity.
    J Virol. 2023 Sep 27:e0060223. doi: 10.1128/jvi.00602.
    >> Share

  394. MCCOOL RS, Musayev M, Bush SM, Derrien-Colemyn A, et al
    Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein elicits antibodies targeting a membrane-proximal epitope.
    J Virol. 2023 Sep 22:e0092923. doi: 10.1128/jvi.00929.
    >> Share

  395. SCHOEN A, Holzer M, Muller MA, Wallerang KB, et al
    Functional comparisons of the virus sensor RIG-I from humans, the microbat Myotis daubentonii, and the megabat Rousettus aegyptiacus, and their response to SARS-CoV-2 infection.
    J Virol. 2023 Sep 20:e0020523. doi: 10.1128/jvi.00205.
    >> Share

  396. FUJITA S, Kosugi Y, Kimura I, Tokunaga K, et al
    Determination of the factors responsible for the tropism of SARS-CoV-2-related bat coronaviruses to Rhinolophus bat ACE2.
    J Virol. 2023 Sep 19:e0099023. doi: 10.1128/jvi.00990.
    >> Share

  397. XING M, Wang Y, Wang X, Liu J, et al
    Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants.
    J Virol. 2023 Sep 14:e0072423. doi: 10.1128/jvi.00724.
    >> Share

  398. CASE JB, Scheaffer SM, Darling TL, Bricker TL, et al
    Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
    J Virol. 2023 Sep 7:e0062823. doi: 10.1128/jvi.00628.
    >> Share

  399. HAN P, Meng Y, Zhang D, Xu Z, et al
    Structural basis of white-tailed deer, Odocoileus virginianus, ACE2 recognizing all the SARS-CoV-2 variants of concern with high affinity.
    J Virol. 2023 Sep 7:e0050523. doi: 10.1128/jvi.00505.
    >> Share

    August 2023
  400. LIN HF, Liu MQ, Jiang RD, Gong QC, et al
    Characterization of a mouse-adapted strain of bat severe acute respiratory syndrome-related coronavirus.
    J Virol. 2023 Aug 21:e0079023. doi: 10.1128/jvi.00790.
    >> Share

  401. LEONARD RA, Rao VN, Bartlett A, Froggatt HM, et al
    A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases.
    J Virol. 2023 Aug 14:e0059723. doi: 10.1128/jvi.00597.
    >> Share

  402. JIN H, Cheng L, Gong Y, Zhu Y, et al
    Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
    J Virol. 2023 Aug 14:e0019223. doi: 10.1128/jvi.00192.
    >> Share

  403. ZHANG W, Shi K, Geng Q, Herbst M, et al
    Structural evolution of SARS-CoV-2 omicron in human receptor recognition.
    J Virol. 2023 Aug 14:e0082223. doi: 10.1128/jvi.00822.
    >> Share

  404. LLEWELLYN GN, Chen HY, Rogers GL, Huang X, et al
    Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides.
    J Virol. 2023 Aug 9:e0068423. doi: 10.1128/jvi.00684.
    >> Share

  405. MYKYTYN AZ, Breugem TI, Geurts MH, Beumer J, et al
    SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models.
    J Virol. 2023 Aug 9:e0085123. doi: 10.1128/jvi.00851.
    >> Share

  406. THOMPSON D, Cismaru CV, Rougier JS, Schwemmle M, et al
    The M2 proteins of bat influenza A viruses reveal atypical features compared to conventional M2 proteins.
    J Virol. 2023 Aug 4:e0038823. doi: 10.1128/jvi.00388.
    >> Share

    July 2023
  407. TALUKDAR SN, McGregor B, Osan JK, Hur J, et al
    Respiratory Syncytial Virus Infection Does Not Induce Epithelial-Mesenchymal Transition.
    J Virol. 2023;97:e0039423.
    >> Share

  408. HICKERSON BT, Petrovskaya SN, Dickensheets H, Donnelly RP, et al
    Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility.
    J Virol. 2023 Jul 5:e0015423. doi: 10.1128/jvi.00154.
    >> Share

  409. JENSEN JL, Sankhala RS, Dussupt V, Bai H, et al
    Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
    J Virol. 2023 Jul 3:e0159622. doi: 10.1128/jvi.01596.
    >> Share

    June 2023
  410. HUANG J, Chen Z, Ye Y, Shao Y, et al
    DTX3L Enhances Type I Interferon Antiviral Response by Promoting the Ubiquitination and Phosphorylation of TBK1.
    J Virol. 2023;97:e0068723.
    >> Share

  411. YANG X, Duan H, Liu X, Zhang X, et al
    Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.
    J Virol. 2023 Jun 27:e0061023. doi: 10.1128/jvi.00610.
    >> Share

  412. TERASAKI K, Narayanan K, Makino S
    Identification of a 1.4-kb-Long Sequence Located in the nsp12 and nsp13 Coding Regions of SARS-CoV-2 Genomic RNA That Mediates Efficient Viral RNA Packaging.
    J Virol. 2023 Jun 27:e0065923. doi: 10.1128/jvi.00659.
    >> Share

  413. LI A, Zhang B, Zhao K, Yin Z, et al
    SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA.
    J Virol. 2023 Jun 22:e0051223. doi: 10.1128/jvi.00512.
    >> Share

  414. GOFFIN E, Du X, Hemmi S, Machiels B, et al
    A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored Vaccine Protects Mice from Influenza Respiratory Infection.
    J Virol. 2023 Jun 20:e0013523. doi: 10.1128/jvi.00135.
    >> Share

  415. CHEN P, Jin Z, Peng L, Zheng Z, et al
    Characterization of an Emergent Chicken H3N8 Influenza Virus in Southern China: a Potential Threat to Public Health.
    J Virol. 2023 Jun 8:e0043423. doi: 10.1128/jvi.00434.
    >> Share

  416. ZHENG H, Ma L, Gui R, Lin X, et al
    Correction for Zheng et al., "G Protein Subunit beta1 Facilitates Influenza A Virus Replication by Promoting the Nuclear Import of PB2".
    J Virol. 2023 Jun 6:e0054623. doi: 10.1128/jvi.00546.
    >> Share

    May 2023
  417. WANG C, Honce R, Salvatore M, Chow D, et al
    Influenza Defective Interfering Virus Promotes Multiciliated Cell Differentiation and Reduces the Inflammatory Response in Mice.
    J Virol. 2023 May 31:e0049323. doi: 10.1128/jvi.00493.
    >> Share

  418. RUNSTADLER JA, Lowen AC, Kayali G, Tompkins SM, et al
    Field Research Is Essential to Counter Virological Threats.
    J Virol. 2023;97:e0054423.
    >> Share

  419. REZENDE W, Ye X, Angelo LS, Carisey AF, et al
    The Efficiency of p27 Cleavage during In Vitro Respiratory Syncytial Virus (RSV) Infection Is Cell Line and RSV Subtype Dependent.
    J Virol. 2023;97:e0025423.
    >> Share

  420. SREENIVASAN CC, Liu R, Gao R, Guo Y, et al
    Influenza C and D Viruses Demonstrated a Differential Respiratory Tissue Tropism in a Comparative Pathogenesis Study in Guinea Pigs.
    J Virol. 2023 May 18:e0035623. doi: 10.1128/jvi.00356.
    >> Share

  421. JIANG H, Joshi A, Gan T, Janowski AB, et al
    The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2.
    J Virol. 2023 May 18:e0063523. doi: 10.1128/jvi.00635.
    >> Share

  422. SLANINA H, Madhugiri R, Wenk K, Reinke T, et al
    Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains.
    J Virol. 2023 May 18:e0046523. doi: 10.1128/jvi.00465.
    >> Share

  423. ISHIMARU H, Nishimura M, Tjan LH, Sutandhio S, et al
    Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants.
    J Virol. 2023 May 16:e0028623. doi: 10.1128/jvi.00286.
    >> Share

  424. ZHANG L, Wang Y, Shao Y, Guo J, et al
    Fine Regulation of Influenza Virus RNA Transcription and Replication by Stoichiometric Changes in Viral NS1 and NS2 Proteins.
    J Virol. 2023 May 11:e0033723. doi: 10.1128/jvi.00337.
    >> Share

  425. SENGAR A, Cervantes M, Bondalapati ST, Hess T, et al
    Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry.
    J Virol. 2023 May 3:e0199222. doi: 10.1128/jvi.01992.
    >> Share

    April 2023
  426. SPECK P, Mackenzie J, Bull RA, Slobedman B, et al
    Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
    J Virol. 2023 Apr 25:e0045123. doi: 10.1128/jvi.00451.
    >> Share

  427. PEACOCK TP, Sheppard CM, Lister MG, Staller E, et al
    Mammalian ANP32A and ANP32B Proteins Drive Differential Polymerase Adaptations in Avian Influenza Virus.
    J Virol. 2023 Apr 19:e0021323. doi: 10.1128/jvi.00213.
    >> Share

  428. KETTUNEN P, Lesnikova A, Rasanen N, Ojha R, et al
    SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
    J Virol. 2023 Apr 11:e0014423. doi: 10.1128/jvi.00144.
    >> Share

  429. LIN SJ, Lin KM, Chen SJ, Ku CC, et al
    Type I Interferon Orchestrates Demand-Adapted Monopoiesis during Influenza A Virus Infection via STAT1-Mediated Upregulation of Macrophage Colony-Stimulating Factor Receptor Expression.
    J Virol. 2023 Apr 6:e0010223. doi: 10.1128/jvi.00102.
    >> Share

    March 2023
  430. TAN Y, Shilts MH, Rosas-Salazar C, Puri V, et al
    Influence of Sex on Respiratory Syncytial Virus Genotype Infection Frequency and Nasopharyngeal Microbiome.
    J Virol. 2023;97:e0147222.
    >> Share

  431. ALWINE JC, Casadevall A, Enquist LW, Goodrum FD, et al
    A critical analysis of the evidence for the SARS-CoV-2 origin hypotheses.
    J Virol. 2023 Mar 10:e0036523. doi: 10.1128/jvi.00365.
    >> Share

  432. WANG X, Wang W, Wang T, Wang J, et al
    SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.
    J Virol. 2023 Mar 6:e0001123. doi: 10.1128/jvi.00011.
    >> Share

  433. MOLS VC, Lamers MM, Leijten LM, Breugem TI, et al
    Intestinal Tropism of a Betacoronavirus (Merbecovirus) in Nathusius's Pipistrelle Bat (Pipistrellus nathusii), Its Natural Host.
    J Virol. 2023 Mar 1:e0009923. doi: 10.1128/jvi.00099.
    >> Share

    February 2023
  434. FROLOV I, Agback T, Palchevska O, Dominguez F, et al
    All Domains of SARS-CoV-2 nsp1 Determine Translational Shutoff and Cytotoxicity of the Protein.
    J Virol. 2023 Feb 27:e0186522. doi: 10.1128/jvi.01865.
    >> Share

  435. ZHANG L, Hom N, Ojha A, Lovendahl KN, et al
    Cytoplasmic Tail Truncation Stabilizes S1-S2 Association and Enhances S Protein Incorporation into SARS-CoV-2 Pseudovirions.
    J Virol. 2023 Feb 15:e0165022. doi: 10.1128/jvi.01650.
    >> Share

  436. WANG X, Wen Z, Cao H, Luo J, et al
    Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.
    J Virol. 2023 Feb 13:e0161122. doi: 10.1128/jvi.01611.
    >> Share

  437. WANG Y, Ge F, Wang J, Li H, et al
    Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained Macrophages and Resident Memory T Cells.
    J Virol. 2023 Feb 13:e0176422. doi: 10.1128/jvi.01764.
    >> Share

  438. AMANAT F, Clark J, Carreno JM, Strohmeier S, et al
    Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination.
    J Virol. 2023 Feb 13:e0166422. doi: 10.1128/jvi.01664.
    >> Share

  439. BEI C, Zhang C, Wu H, Feng H, et al
    DDX3X Is Hijacked by Snakehead Vesiculovirus Phosphoprotein To Facilitate Virus Replication via Stabilization of the Phosphoprotein.
    J Virol. 2023 Feb 6:e0003523. doi: 10.1128/jvi.00035.
    >> Share

  440. SCHINDEWOLF C, Lokugamage K, Vu MN, Johnson BA, et al
    SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.
    J Virol. 2023 Feb 1:e0153222. doi: 10.1128/jvi.01532.
    >> Share

    January 2023
  441. GOODRUM F, Lowen A, Lakdawala S, Alwine J, et al
    Virology under the Microscope-a Call for Rational Discourse.
    J Virol. 2023 Jan 26:e0008923. doi: 10.1128/jvi.00089.
    >> Share

  442. LIU MQ, Lin HF, Li J, Chen Y, et al
    A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice.
    J Virol. 2023 Jan 23:e0171922. doi: 10.1128/jvi.01719.
    >> Share

  443. RAJAGOPALA SV, Strickland BA, Pakala SB, Kimura KS, et al
    Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
    J Virol. 2023 Jan 19:e0147822. doi: 10.1128/jvi.01478.
    >> Share

  444. MA J, Liu X, Zhou M, Chen P, et al
    A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
    J Virol. 2023 Jan 18:e0168422. doi: 10.1128/jvi.01684.
    >> Share

    September 2021
  445. TANG W, Li Y, Song Q, Wang Z, et al
    Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein.
    J Virol. 2021;95:e0120521.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016